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There is a growing interest in the genotoxic effects of low levels of ionising 
radiation, most recently (but certainly not only) because of the nuclear 
accident at Fukushima Daiichi Nuclear Power Plant in Japan. There is still 
controversy about the effects of low levels (<0.25 Gy) of ionising radiation via 
environmental, occupational, clinical and accidental exposures. The 
development of cellular and molecular biomarkers is important in assessing 
the exposure and for predicting future adverse health outcomes. It was earlier 
shown that even many years after occupational exposure, a significant 
fraction of the cells of Mayak plutonium workers contained large 
intrachromosomal rearrangements (Hande et al., 2003, Mitchell et al., 2004) 
and complex chromosomal exchanges  (Hande et al., 2005). Many attempts 
have been made to identify biomarkers which can be used for high throughput 
biodosimetry screening. In this study, we focussed on the effects induced by 
exposure to different doses of gamma radiation (0.1 to 1.0 Gy) on human 
lymphocytes. By comparing the results of the classical cytogenetic assays 
with gene expression profiles from lymphocytes of ten different donors, we 
identified a set of signature marker genes which could be used to complement 
current biomarkers for the prediction of dose of exposure. The results showed 
signs of inter-individual variation which is important in determining individual 
susceptibility to radiation exposure. Inter-individual variation in radiosensitivity 
is a critical for the development of gene expression biomarkers. Therefore, we 
identified a set of marker genes for radiosensitivity, which are specific for the 
individuals who are more susceptible to radiation and checked if we could find 
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a dose-dependent response. Although further studies of inter-individual 
variation in larger population need to be done, these identified biomarkers can 
be used to detect heterogeneity in radiosensitivity. This is important for the 
identification of individual radiosensitivity which can be used to identify 
individual risks during occupational and clinical exposures. The ultimate goal 
is to use these markers for preventive tests so that medical treatment can be 
tailored to individual’s radiosensitivity.  
To investigate whether the cytogenetic and molecular markers are specific to 
gamma radiation, we extended our study by using heavy ion radiation of 
human lymphocytes. As expected, we found that heavy ions are many fold 
more effective than gamma radiation in inflicting damage to the cells. 
Interestingly, the different types of radiation exhibited variation in both – the 





LIST OF TABLES 
Table No. Title Page 
Table 1 Recommended radiation weighting factors 10 
Table 2 Recommended tissue weighting factors 11 
Table 3 
Micronuclei (MN) in cytokinesis-blocked lymphocytes 




A. Percentage of cytokinesis-blocked binucleated 
cells (BN) with micronuclei (MN)  
B. Percentage of MN following exposure to 
different doses of gamma radiation 
49 
Table 5 
Analysis of chromosomal aberrations in metaphases 
from human peripheral blood lymphocytes after 
exposure to various doses of gamma radiation 
54 
Table 6 
A. Gene expression profiles 2 hours post gamma 
irradiation 
B. Gene expression profiles 24 hours post 
gamma irradiation 
C. Genes differentially expressed after gamma 
radiation at 2 and 24 hours post-irradiation 
66 
Table 7 Comparison of gene expression between the most 
radiosensitive and most radioresistant donor 
71 
Table 8 
Analysis of chromosomal aberrations in metaphases 
from human peripheral blood lymphocytes after 
exposure to various doses of carbon ions 
88 
Table 9 
Ratio of chromosomal aberrations in metaphases from 





Table No. Title Page 
Table 10 Most significant genes after exposure to different 
doses of carbon ions 
99 
Table 11 
Analysis of chromosomal aberrations in metaphases 
from human peripheral blood lymphocytes after 
exposure to various doses of iron ions 
102 
Table 12 
Ratio of chromosomal aberrations in metaphases from 
human lymphocytes after exposure to 1 Gy of iron 
ions 
105 
Table 13 Most significant genes after exposure to different 





LIST OF FIGURES 
Figure No. Title Page 
Figure 1 




Schematic summary of the conventional paradigm in 
radiobiology 
9 
Figure 3 Relative doses from common radiation sources 12 
Figure 4 
Commonly observed chromosomal aberrations upon 
radiation exposure 
20 
Figure 5 Schematic diagram of micronucleus formation in a cell  25 
Figure 6 
Various possible fates of cultured cytokinesis-blocked 
cells following exposure to genotoxic events like 
exposure to ionising radiation 
27 
Figure 7 Phosphorylation events in the initiation of HR 28 
Figure 8 
γH2AX foci following gamma radiation as a measure 




Cytokinesis Blocked Micronucleus (CBMN) assay for 




Telomere PNA-FISH was used to detect chromosomal 
aberrations in metaphases 
53 
Figure 11 
Chromosome aberrations observed in human 





Figure No. Title Page 
Figure 12 
Chromosomal rearrangements in human lymphocytes 
exposed to 1 Gy gamma radiation by mFISH 
58 
Figure 13 
Ratio of chromosome rearrangements in human 
lymphocytes after exposure to 1 Gy gamma radiation 
59 
Figure 14 
Distribution of aberrations in all chromosomes after 
exposure to 1 Gy gamma radiation 
60 
Figure 15 
Hierarchical clustering of gene expressions following 




Representative images of principal component 
analysis of various data points 
63 
Figure 17 
Venn Diagram of numbers of significantly differential 
expressed genes following exposure tovarious doses 
of gamma radiation 
65 
Figure 18 
Venn diagram of numbers of significantly differential 
expressed genes between most radiosensitive and 
most radioresistant donor  
70 
Figure 19 
Bragg’s curve that shows the energy distribution of 




Chromosome aberrations observed in human 




Chromosome rearrangements in human lymphocytes 
exposed to 1 Gy carbon ions by mFISH 
94 
Figure 22 
Ratio of chromosome rearrangements in human 




Figure No. Title Page 
Figure 23 
Distribution of aberrations in all chromosomes after 
exposure to 1 Gy carbon ions 
95 
Figure 24 
Principal component analysis of various data points 
following carbon ion exposure 
97 
Figure 25 
Venn Diagram of numbers of significantly differentially 
expressed genes following carbon ion exposure 
98 
Figure 26 
Chromosome aberrations observed in human 




Chromosomal rearrangements in human lymphocytes 
exposed to 1 Gy iron ions by mFISH 
106 
Figure 28 
Ratio of chromosome aberrations in human 
lymphocytes after exposure to 1 Gy iron ions 
107 
Figure 29 
Distribution of aberrations in all chromosomes after 
exposure to 1 Gy iron ions 
107 
Figure 30 
Principal component analysis of various data points 
following iron ion exposure 
109 
Figure 31 
Venn Diagram of numbers of significantly differentially 
expressed genes following iron ion exposure 
110 
Figure 32 
Dicentric formation induced by different kinds of 
radiation 
114 
   
 XIV 
 
LIST OF ABBREVIATIONS 
γH2AX Phosphorylated Histone H2A Variant 
BN Binucleated  
CBMN Cytokinesis Blocked Micronucleus 
DCA Dicentric Chromosome Assay 
DSB Double Strand Break  
DSBR Double Strand Break Repair  
FITC Fluorescein Isothiocyanate 
FISH Fluorecence In Situ Hybridisation 
HR Homologous Recombination  
LET Linear Energy Transfer 
LTN Linear No-threshold 
mFISH Multicolour Fluorescence In Situ Hybridisation 
MN Micronuclei 
mSv Millisieverts 
NER Nucleotide-excision Repair  
NHEJ Non-homologous End Joining  
PBMCs Peripheral Mononuclear Cells 
PBS Phosphate Buffered Saline 
PNA Peptide Nucleic Acid 
RBE Relative Biological effectiveness 
ROS Reactive Oxygen Species 
SSB Single Strand Break 




LIST OF CONFERENCE PRESENTATIONS 
D. Zeegers, S Sethu, P Srikanth, M Jayapal, GKM Low, RL Gurung, B 
Banerjee, T Kato, A Fujimori, R Okayasu, MP Hande. A multiparametric 
approach to study the effects of low doses of densely ionized radiation in 
human peripheral blood lymphocytes. International Congress of Radiation 
Research, Aug 28-Sept 1 2011, Warsaw, Poland. 
MP Hande, D Zeegers, S Sethu, RL Gurung, M Jayapal, B Banerjee, R 
Baskar, S Loong, T Kato, R Okayasu, PGS Prasanna. In the persuit of 
identifying biomarkers of radiation exposure in human lymphocytes: a multi-
parametric approach. International Congress of Radiation Research, Aug 28-
Sept 1 2011, Warsaw, Poland. 
GKM Low, D Zeegers, YK Phoon, S Sethu, M Jayapal, MP Hande. Effects of 
Arsenite on human cells. International Symposium on Environmental 
Exposures to Mutagens and Carcinogens on Human Health. Feb 4-6 2011, 
Vellore, Tamilnadu, India. 
D Zeegers, S Sethu, P Srivastava, GKM Low, M Jayapal, P Srikanth, B 
Banerjee, AK Khaw, T Kato, R Okayasu, MP Hande. Biomarkers of radiation 
exposure in human lymphocytes: A multiparamtric approach. International 
Symposium on Environmental Exposures to Mutagens and Carcinogens on 
Human Health, Feb 4-6 2011, Vellore, Tamilnadu, India. 
D Zeegers, S Sethu, RL Gurung, GKM Low, M Jayapal, B Banerjee, R 
Baskar, S Loong, T Kato, R Okayasu, PGS Prasanna, MP Hande. Biomarkers 
of radiation exposure in human lymphocytes: a multiparametric approach. The 
 XVI 
 
Inaugural Yong Loo Lin School of Medicine Graduate Scientific Congress. Jan 
25, 2011, National University of Singapore, Singapore. 
D Zeegers, S Sethu, RL Gurung, B Banerjee, R Baskar, S Loong, T Kato, R 
Okayasu, MP Hande. In the persuit of identifying biomarkers of radiation 
exposure in human lymphocytes: A multiparametric approach. Annual general 
and scientific meeting, Microscope Society (Singapore) 2013, 10th April 2013, 




LIST OF PUBLICATIONS 
El Ghamrasni S, Cardoso R, Halaby MJ,  Zeegers D, Harding S, 
Kumareswaran R, Yavorska T, Chami N, Jurisicova A, Sanchez O, Hande 
MP, Bristow R, Hakem R, Hakem A. Cooperation of Blm and Mus81 in 
development, fertility, genomic integrity and cancer suppression. Oncogene. 
2014 May 26;1-10. 
Bull CF, Mayrhofer G, O'Callaghan NJ, Au AY, Pickett HA, Low GK, Zeegers 
D, Hande MP, Fenech MF. Folate deficiency induces dysfunctional long and 
short telomeres; both states are associated with hypomethylation and DNA 
damage in human WIL2-NS cells. Cancer Prevention Research (Phila). 2014 
Jan;7(1):128-38. 
Lim SN, Yahya Z, Zeegers D , Moe T, Kyaw EE, Yeo SH, Hande MP and Tan 
EC. Distribution of Telomere Length in the Cord Blood of Chinese Newborns. 
British Journal of Medicine and Medical Research. 2013 March; 3(4):1004. 
Bull CF, Mayrhofer G, Zeegers D, Mun GL, Hande MP, Fenech MF. Folate 
deficiency is associated with the formation of complex nuclear anomalies in 
the cytokinesis-block micronucleus cytome assay. Environental and Molecular 
Mutagenesis. 2012 May;53(4):311-23. 
Bohgaki T, Bohgaki M, Cardoso R, Panier S, Zeegers D, Li L, Stewart GS, 
Sanchez O, Hande MP, Durocher D, Hakem A, Hakem R. Genomic instability, 
defective spermatogenesis, immunodeficiency, and cancer in a mouse model 
of the RIDDLE syndrome. PLoS Genetics. 2011 Apr;7(4):1-16. 
 XVIII 
 
Jayapal M, Sethu S, Zeegers D, Banerjee B, and Hande MP. Predictive 
Genomics: A Post-genomic Integrated Approach to Analyse Biological 








Biomarkers are important in assessing the exposure and for predicting future 
adverse health outcomes. The development of cellular and molecular 
biomarkers is an important goal in cancer research and biodosimetry. In this 
study, we focus on the effects induced by exposure to doses of radiation on 
human lymphocytes from 0.1 to 1.0 Gy and try to use the findings towards the 
estimation of a radiation dose received by an individual. Efficient and accurate 
assessment of radiation exposure is needed to support the triage of radiation 
casualties (Grace et al., 2010). Humans are exposed to radiation either due to 
their occupation, therapy or accidentally (Wakeford, 2004). In these 
circumstances, it is essential to determine the level of exposure to take 
necessary medical action or modification of work schedule. While the need for 
biodosimetry is essential at levels that might induce acute radiation 
syndrome, it is important to identify low dose exposure, as in the presence of 
combined injury, relatively low levels of radiation (<1 Gy) can lead to 
aggravated injuries (Feinendegen et al., 2004, Royal, 2008, Swartz et al., 
2010). 
During potential scenarios of a large-scale radiological event which result in 
mass casualties, it is crucial to be able to make decision about to whom 
immediate medical attention should be given (Loeffler and Durante, 2013, 
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Wojcik et al., 2010). Dose estimates are essential to assign medical attention 
according to an individual’s needs (Romm et al., 2011). Treatment should be 
initiated within 24-48 hours after the event (Lloyd, 1997). Current 
biodosimeters are available but high-throughput methods to screen large 
populations are important and required (Wojcik et al., 2010). The currently 
accepted method for radiation biodosimetry is the dicentric assay which may 
be difficult to be employed in mass triage situations because it is time 
consuming and requires highly trained personnel for scoring (Flegal et al., 
2010, Vaurijoux et al., 2009). Many attempts have been made to identify 
biomarkers which can be used for high-throughput biodosimetry screening 
(Paul and Amundson, 2008, Chauhan et al., 2014, Sullivan et al., 2013, 
Tucker et al., 2014). In this study, we compare the results of the classical 
cytogenetic assays with gene expression profiles in peripheral blood 
lymphocytes of ten healthy individuals. The cytogenetic results provide more 
information about the physiological state of the cells, which contributes to a 
more reliable interpretation of the gene expression results. The potential 
biomarkers genes which are found can be used to complement current 




1.2 Literature review  
1.2.1 Ionising radiation 
Radiation is a generic term which describes a flux of elementary particles and 
is the emission of energy without direct contact. Radiation can be caused by 
many physical processes, like radioactive decay, nuclear fission or fusion, or 
gases which can radiate under the influence of electric current. These 
radiations can occur in the form of waves (electromagnetic radiation) or in the 
form of high speed particles (particle radiation, like alpha and beta particles) 
(Hall and Giaccia, 2006). Electromagnetic radiation can travel through empty 
space. All forms of electromagnetic radiation reside on the electromagnetic 
spectrum based on the difference in wavelength. The higher the energy levels 
of the photon, the further it can penetrate and the more harmful the radiation 
is. All electromagnetic radiation consists of photons, the only difference is the 
wavelength and the energy level of the photons (Hall and Giaccia, 2006).  
Radiation can be classified in different ways. One way is to classify based on 
the effects induced which can be divided into two categories: ionising and 
non-ionising radiation (Ritter and Durante, 2010). Non-ionising radiation is 
radiation that has enough energy to move atoms around or make them 
vibrate but not enough energy to remove electrons; examples are sounds, 
visible light and microwaves. Although non-ionising radiation is considered 
less dangerous than ionising radiation, excessive exposure to non-ionising 
radiation such as ultraviolet (UV) light can cause health issues (Mancebo and 
Wang, 2014).  
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Ionising radiation has enough energy to break chemical bonds and remove 
tightly bound electrons from atoms. This will cause ionisation, a process 
where electrons are removed from atoms or molecules, creating electric 
particles called ions. Ions can cause chemical changes in the irradiated 
sample and damage the DNA randomly and are therefore dangerous and 
induce different changes (Hall and Giaccia, 2006). The ion can either interact 
directly with the DNA or may interact with another molecule or atom which 
produces free radicals which are able to diffuse far enough to reach and harm 
the surrounding DNA (Figure 1). This is known as the indirect action of 
radiation; and both ways result in stochastic DNA damage in the cells 
(Teoule, 1987, Ward, 1988). 
  
Figure 1 
Overview of direct and 
indirect actions of ionising 
radiation. Direct action means 
that the photon removes the 
electron which directly interacts 
with the DNA; while the indirect 
action is the interaction of the 
electron with molecules in the 
cell (mostly H2O) which forms 
free radicals that can diffuse 
and harm the DNA. Both 
actions result in the same kind 
of damage to the DNA. 













There are many types of radiations and radioactive emissions. Depending on 
the amount of energy, radiation behaves either like a wave or a particle. This 
is called wave particle duality. UV light, X-rays and gamma rays are examples 
of electromagnetic radiation which travel as waves. When an unstable atom 
disintegrates, it can produce particle radiation (Goodhead et al., 1993). Alpha 
particles, (α) are positively charged and made up of protons and neutrons. 
They travel short distance and can be blocked easily. Alpha particles are the 
most harmful when they enter the body, for example, by inhalation or 
ingestion. Beta (β) particles can penetrate through thicker surfaces than alpha 
particles and can be either positively or negatively charged, fast moving 
electrons. Depending on the energy the beta particle carries, it can penetrate 
the skin and cause burns; and like alpha particles, they too are dangerous 
upon entry through inhalation or ingestion (Hall and Giaccia, 2006). 
Among all forms of electromagnetic radiation, gamma rays (γ) have the 
shortest of wavelengths (less ionising) but the greatest energy and have 
therefore a higher capacity to penetrate (Hall and Giaccia, 2006). They are 
part of the electromagnetic spectrum but they emit ionising radiation because 
of their high energy. Gamma rays contain photons which have no charge but 
are often accompanied by alpha and beta particles, gamma rays can 
penetrate easily and are difficult to block and therefore hazardous to the body 
(Hall and Giaccia, 2006). 
Another form of particle radiation is heavy ion radiation. Particles with a mass 
heavier than helium are considered heavy ions and since they have greater 
mass, the distribution of primary events and excitations along the track is 
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different from that of proton radiation (Tobias et al., 1982). A term to 
distinguish the difference is linear energy transfer (LET), which indicates the 
average energy deposited per unit length of track (Ke/µM). Various types of 
radiation vary significantly in LET values. Exposure to low LET radiation, or 
sparsely ionising radiation (like X-rays, gamma rays), leads to random 
distribution of ionisation which results in random distribution of aberrations 
among cells (Dingfelder et al., 2006). In contrast, high LET radiation or dense 
radiation (alpha-particles or neutrons) radiates clusters of energy and 
therefore results in non-random distribution of chromosomal aberrations. This 
will produce localised DNA damage at chromosomal level and lead to more 
cells with multiple aberrations and less with single aberration (Hande et al., 
2003, Tobias et al., 1982, Sekine et al., 2008). The effects of heavy ion 
radiation will be discussed in more detail in chapter 4. 
1.2.2 Repair of DNA damage induced by ionising 
radiation 
Radiation can harm the DNA molecules by giving rise to primary lesions and 
influence the DNA repair mechanisms (Limoli et al., 1997). Exposure of cells 
to ionising radiation can also result in oxidative stress due to the formation of 
reactive oxygen species (ROS) (Kam and Banati, 2013). ROS can induce 
DNA damage that can be manifested as single (SSB) or double strand breaks 
(DSB), unstable hydrogen bonds between complementary strands, base-
modifications, simple base deletions, insertions or point mutations, inter- and 
intra-strand crosslinks or adducts between adjacent bases (Pollycove and 
Feinendegen, 2003, Sancar et al., 2004). This may change the DNA helix 
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structure and interfere with vital cellular processes such as DNA replication 
and transcription which are necessary for cell survival, reproduction and 
development as well as tissue renewal and function (Hoeijmakers, 2009). As 
a response, the cell activates the DNA damage control system to prevent, 
repair or remove the DNA damage incurred (Hoeijmakers, 2001). DNA 
damage control system involves a dynamic process to maintain the 
homeostasis of the organism (Teoule, 1987, Ward, 1988). Damages induced 
in the DNA might result in chromosomal alterations due to irregular DNA 
repair processes (Difilippantonio et al., 2002, Tabocchini et al., 2012). If 
chromosomal aberrations persist or are misrepaired, they can result in 
genomic instability eventually leading to tumour formation which might have 
immediate consequences and can be transmitted to the cell progeny 
(Hoeijmakers, 2009).  The variability of response has been shown to depend 
on genotype and the physiological state of the cells therefore levels of 
radiation which induce an extremely small cancer risk might vary among 
individuals (Paul and Amundson, 2011). 
Ionising radiation induces many different types of physical and biological 
damage in the cells. Different cellular lesions like base damage, cross-links 
and strand breaks occur within the cells (Tabocchini et al., 2012). It has been 
estimated that if a single cell is exposed to 1 Gy low-LET radiation such as 
gamma radiation, it results in an average of 1000 SSBs and 40 DSBs 
(Goodhead et al., 1993). It has been shown that there is a close relationship 
between radiation-induced DSBs, occurrence of chromosomal aberrations 
and cell transformation (Bryant, 1984, Yang et al., 1989, Akpa et al., 1992). 
Therefore, although DSBs are relatively infrequent, they are considered the 
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major cause of biological effects induced by irradiation (Obe et al., 2010). The 
induced DNA damage triggers signalling which activates DNA repair 
processes within the cells. The fate of a cell following any DNA damage 
depends on the gravity of the damage and could potentially result in cell 
death or senescence (Hoeijmakers, 2001, Hoeijmakers, 2009). Irreparable 
DNA damage usually results in apoptosis, as an anti-tumour mechanism. In 
contrast, a cell pauses during the cell cycle to activate DNA repair 
mechanisms to reverse the damage (Feinendegen et al., 2004). In general, 
DSBs can be repaired in two ways. When the original sequence is restored 
with the use of an intact identical sequence by homologous recombination 
(HR), no sequence will be lost (Sancar et al., 2004). Alternatively, DSBs are 
repaired by non-homologous end joining (NHEJ) pathway – a more rapid 
repair process, but a more error-prone one (Goodhead, 2010). If the repair is 
unsuccessful but the cell survives, it may lead to a permanent DNA 
modification which can either lead to senescence or potentially promote 










Schematic summary of the conventional paradigm in radiobiology. An 
understanding of the effects of radiation exposure can help to identify 
biomarkers of radiation exposure. Direct and indirect ionisation induces 
damage to the DNA in the form of base damage (BD), single strand breaks 
(SSB) and double strand breaks (DSB). DNA repair can lead to three different 
outcomes: cell death, perfect repair or a viable cell with a permanent DNA 
modification (Goodhead, 2010). Detailed description can be found in text 
body, section 1.2.2 ‘Repair of DNA damage induced by ionising radiation.’ 




1.2.3 Units used to express radiation exposure 
Radiation exposure is commonly expressed as absorbed dose, defined as the 
energy deposited to the mass of exposed body or organ as a result to ionising 
radiation. The international system of units (SI system) for radiation 
measurement uses "gray" (Gy) where 1 Gy is equivalent to 1 J/kg (ICRP, 
1990). In this study, we will use the absorbed dose. 
The equivalent dose includes the radiation weight factor which discriminates 
between the different types of radiation which can harm in varying 
magnitudes. High LET has more impact than low LET radiation. For gamma 
and X-rays the radiation weight factor is 1 (Table 1) and therefore the 
absorbed dose and equivalent dose are the same. The international system 
of units (SI system) for equivalent dose uses "gray" (Gy) and "sievert" (Sv). 
The weighting factor for heavy ions is 20, which is what makes heavy ion 
radiation is more powerful in cell killing and therefore a more effective but also 
a more damaging way to treat the cells (ICRP, 1991). 
  Radiation type   Radiation weighting factor, wR 
    Photons 1 
  Electrons
a
 and muons   1 
  Protons and charged pions 2 
 Alpha particles, fission fragments,heavy ions   20 
  Neutrons   A continuous function of neutron energy   
 
    All values relate to the radiation incident on the body or, for internal radiation sources, 
  emitted from the incorporated radionuclide(s). 
     
a
 Note the special issue of Auger electrons discussed in ICRP 103 (2007). 
 
Table 1 




1.2.3.1 Effective dose 
Another aspect of importance is the tissue weight factor which helps 
discriminate between full body and partial body exposure. Some tissues are 
more susceptible to radiation and have a higher weight factor. The highest 
weight factor is full body exposure, which is 1 (Table 2). So, in case we talk 
about the effects of radiation on the human body, we mostly show effective 
dose (Wakeford, 2004). For this study, we make use of blood samples 
therefore we use the absorbed dose. The international system of units (SI 
system) for effective dose uses "sievert" (Sv). 
 
  Tissue wT ΣwT 
  Bone marrow (red), Colon, Lung, Stomach, Breast, Remainder tissues* 0.12 0.72 
  Gonads 0.08 0.08 
  Bladder, Oesophagus, Liver, Thyroid 0.04 0.16 
  Bone Surface, Brain, Salivary glands, Skin 0.01 0.04 
 
Total 1.00 
      * Remainder tissues: Adrenals, Extrathoracic (ET) region, Gall bladder, Heart, Kidneys, Lymphatic nodes, 
Muscle, Oral mucosa, Pancreas, Prostate(♂), Small intestine, Spleen, Thymus, Uterus/cervix(♀). 
 
Table 2 
Recommended tissue weighting factors, from (ICRP, 2007) 
1.2.3.2 Natural background radiation 
Every one of us is constantly being exposed to some sort of radiation source. 
Natural radiation originates from many sources including more than 60 
naturally occurring radioactive materials in the air (cosmic), soil and water 
(terrestrial). These natural levels of radiation exposure are considered as 
background radiation and vary among individuals. According to World Health 
Organisation (WHO), each person is exposed to an average of 2.4 mSv 
ionising radiation a year due to background radiation. Besides natural 
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radiation, we are being exposed to man-made sources of radiation from 
medical, commercial and industrial activities (Figure 3). Whether or not the 
radiation is harmful to the body depends on the dose, type and dose rate of 
radiation (Royal, 2008, Vatansever and Hamblin, 2012). The identification of 
the effects of low dose radiation exposure can help to identify radiation-
related cancer mortality risk associated with full-body computed tomographic 
(CT) examination (Brenner 2004). 
 
Figure 3 
Relative doses from common radiation sources. Levels adapted from 
EPA, Relative doses from radiation sources. Medical tests are the major 
sources of annual radiation exposure. A full body CT scan accounts for 
10mSV while no direct beneficial effects are connected with full body CT 
scans (Brenner and Elliston, 2004). Knowledge about the effects of low dose 
radiation exposure would be useful in making reliable justification for 






Since DNA damage occurs randomly, we aim to address the complex kinetics 
and dynamics of multiple end points/biomarkers on post-irradiation functional 
relevance. Radiation induces a wide variety of molecular, cellular and 
physiological changes in exposed organisms, tissues and cells. Therefore 
different parameters can be used as biomarkers. We classified radiation 
biomarkers into two different categories – biomarkers of exposure and 
biomarkers of sensitivity.  
1.2.4.1 Biomarkers of exposure 
Ionising radiation is known to be harmful to the human body, the nature and 
severity of the damage is proportional to the absorbed dose (Feinendegen et 
al., 2004). Biomarker of exposure is the biological response to radiation 
exposure which depends on the dose of exposure. These biomarkers are 
commonly called biodosimeters and can help to reconstruct and predict 
effects in the case of accidents or occupational exposure (Brooks, 1999). For 
biodosimetry measures to be suitable to make estimations of dose, dose 
equivalent and risk, there are a few important requirements. Firstly, the 
biomarkers have to be radiation-specific as individual background levels will 
be unknown. Secondly, it is important that used biomarkers persist after 
radiation exposure, to provide dose estimation upon the time of sampling. 
Lastly, the sensitivity threshold of the methods is important (Blakely et al., 
2001). The effects of low dose exposure should be greater than background 
and inter-individual levels (Pollycove and Feinendegen, 2003). These 
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biodosimeters are of great importance, in case, a big population is exposed to 
unknown dose of radiation like in Fukushima, Japan in March 2011. An 
earthquake, followed by a tsunami, led to explosion of parts of the nuclear 
plant and a big population being exposed to unknown levels of radiation. If 
screening methods with the use of biomarkers are available, it will help make 
crucial decisions to provide medical attention. During this event and in the 
earlier accidents such as the one in Goiania (Ramalho and Nascimento, 
1991), an attempt was made to use dicentric analysis as biodosimeter 
(Natarajan et al., 1991a, Natarajan et al., 1991b, Straume et al., 1991). This 
takes 68 - 72 hours before results can be obtained and need well trained 
personnel to analyse. Therefore, there is need for a faster, high-throughput 
biodosimeter so that people can be grouped according to their needs and 
medical attention can be divided in a more efficient manner (Sullivan et al., 
2013). 
Another aspect is that these biodosimeters will give more information about 
low dose radiation exposure and will be useful to make rational decisions if 
the use of radiation exposure is justified; for example, in use of the 
backscatter scanners or time duration of space exploration (Brenner, 2011). 
Without knowing the long-term effects of exposure to low-dose radiation, it is 
difficult to define an extremely low increase in cancer risk (Brenner, 2011).  
1.2.4.2 Biomarkers of sensitivity 
Biomarkers of sensitivity depend on individual susceptibility to radiation 
damage. This takes the genetic background and physiological state of the 
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cells into account. Despite the harm radiation inflicts, radiation is still 
commonly used as a diagnostic method to detect illness or malady that may 
afflict a patient. In addition, radiotherapy is the most important non-surgical 
modality for the curative treatment of cancer which is currently used in 50% of 
all cancer patients (Delaney et al., 2005, Begg et al., 2011). As the intensity of 
the cytotoxic side effects vary among patients, individual pre-screening for 
biomarkers of radiation sensitivity can help to determine individualised toxicity 
risks regarding radiation exposure and in the end, to determine individual 
risks before medical exposure (Paul and Amundson, 2011). The search for 
biomarkers that may identify radiosensitivity by the use of gene expression 
has not been successful to date. This is mainly due to individual variation in 
gene expression (Paul and Amundson, 2008). Another strategy is to analyse 
gene expression changes in genes that are important for DNA repair and cell 
cycle checkpoints. These are likely to be affected by radiation exposure and 
differences in response between individuals might give more information 
about genes important to individual radiation sensitivity (Kabacik et al., 2011). 
It is difficult to find a set of genes which can give information exclusively about 
response to radiation. Individual radiation sensitivity is important for 
biodosimetry measures as it affects the outcome of dose estimation 
measurement. If biomarkers for radiation sensitivity are identified, these 
would be of great use in pre-medical screening. This will help in stratification 
of individuals – based on their sensitivity to radiation, the dose and fractions 





Cytogenetics is the study of the structure and composition of the 
chromosomes. Its application depends upon methods that can help to identify 
chromosome numbers and structures and identify alterations of the 
chromosomes which eventually may lead to genomic instability. In 1956 Tijo 
and Levan used cytogenetic techniques to determine the human chromosome 
number to be 46 (Dave and Sanger, 2007). This has led to the identification of 
the numerical aberration in patients with Down’s syndrome in 1958 and 
Klinefelter syndrome and Turner syndrome in 1959 (Jacobs and Strong, 
1959, Ford et al., 1959). In tumour cytogenetics this led to the identification of 
the Philadelphia chromosome, which was often found in peripheral blood of 
patients with myeloid leukaemia (Nowell and Hungerford, 1964). Since then, 
major advancement has been made in the field of cytogenetics owing to an 
increase in the specificity and resolution of chromosome staining methods. 
The introduction of Q-banding (Patil et al., 1971) and G-banding (Seabright, 
1971) allowed for the identification and classification of each pair of 
chromosomes. This revealed that the Philadelphia chromosome was not the 
result of a deletion in chromosome 22 but a translocation between 
chromosome 9 and 22 (Rowley, 1973). With the development of 
Fluorescence In Situ Hybridisation (FISH), the resolution and ease of 
analysing samples has greatly improved. Currently the use of multi-coloured 
probes that can help identify inter- and intra-chromosomal translocation and 
probes to screen for specific loci are commercially available. It can provide 
information about the occurrence of chromosome-specific breaks, fusions and 
translocations. Accumulated cytogenetic data has revealed that cytogenetic 
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analysis of the karyotype (the entire set of chromosomes of a cell) can inform 
the physician of the cancer progression and prognosis. WHO has now 
categorized 4 unique AML subtypes according to cytogenetics (Vardiman et 
al., 2009). Therefore, cytogenetic techniques have become an important tool 
for clinical diagnostics, disease prognosis and risk estimation of populations 
exposed to DNA damaging agents such as radiation. However, analysis is 
time consuming and laborious as extensive expertise is required for the 
deployment of these techniques. 
1.2.5.1 Chromosome components and their function 
The fundamental component of eukaryotic chromosomes is the chromatin, 
which consists of DNA complexes with proteins and histones. The DNA 
double helix is packed around the nucleosomes (Strachan and Read, 1999). 
The most fundamental unit of packing is in the nucleosome which consists of 
a central core complex of eight basic histone proteins (H2A, H2B, H3 and 
H4). Nucleosomes are connected with a small part of spacer DNA or linker 
DNA (Strachan and Read, 1999). A string of nucleosomes is coiled onto a 
chromatin fibre which consists of euchromatin and heterochromatin regions. 
Euchromatin are the less densely packed regions which often consist of 
gene-dense regions, while the more tidily packed regions called 
heterochromatin consists of gene-poor regions. Every chromosome consists 
of two chromatids, which are connected at the centromere. To the centromere 
region the kinetochore is connected, which contains the mircotubuli with the 
chromosome. During mitosis, the chromosome is separated into two 
chromatids which are each translocated to two different nuclei. Telomeres are 
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nucleoprotein structures on the ends of linear chromosomes consisting of the 
non-coding tandem hexameric DNA repeats, TTAGGG (de Lange, 2001). 
Telomeres serve two major functions; first, the telomeres protect the coding 
genome against the end replication problem and are thus thought as the 
biological clock of the cells (Harley et al., 1990). Second, they act as 
protective caps against chromosomal degradation and recombination (Artandi 
and Attardi, 2005, de Lange, 2001). Dysfunctional telomeres may lead to 
chromosomal fusions that will lead to genomic instability and initiation of 
carcinogenesis (Artandi and Attardi, 2005). In this study, we make use of 
probes complementary to the telomeres and centromere regions. This helps 
to analyse chromosome structure accurately and facilitates the detection of 
dicentric chromosomes.  
1.2.5.2 Chromosomal abnormalities 
Meiotic and mitotic errors can produce endless combinations of chromosome 
abnormalities (Goodhead, 1994). But in practice, only certain types of 
abnormalities are tolerated and can be identified. In general, loss of 
chromosomal material is less tolerated than gain of chromosomal material, 
although it also depends if it contains euchromatic or heterochromatic 
material (Torres et al., 2008). Chromosomal abnormalities can involve a 
change of number of chromosomes or structural changes which involve 
rearrangements of chromosomes (Limoli et al., 1997). Chromosomal 
abnormalities can occur spontaneously or can be induced by physical or 
chemical agents. Ionising radiation is an efficient inducer of structural 
chromosomal aberrations. The ends of broken chromosomes have three 
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fates: they can be restituted, they can remain open, or the ends may rejoin 
illegitimately with other breaks (Artandi and Attardi, 2005, de Lange, 2001). 
More than 90% of primary breaks induced by ionising radiation are restituted 
(Savage and Tucker, 1996). If the chromosome ends stay open, it can be 
seen as simple breaks while if they rejoin it will result in different types of 
chromosomal exchanges (Figure 4). Like dicentrics, which are unstable 
exchanges that result from joining of two centric fragments, this often comes 
with an acentric fragment and is commonly observed following exposure to 
ionising radiation. Translocations are stable exchanges and can be 
subdivided into reciprocal, interstitial and complex translocations (Durante et 
al., 2004, Mitchell et al., 2004, Ritter and Durante, 2010). While reciprocal 
translocations involve two broken chromosomes, interstitial translocations 
involve the excision of a fragment located between two breakpoints. Complex 
translocations involve three or more breaks in two or more chromosomes 
(Savage and Simpson, 1994). Ring chromosomes are derived by joining of 
the two ends of a chromosome segment, where centric rings are able to pass 












































Commonly observed chromosomal aberrations upon radiation 
exposure. Table taken with permission from (Tucker et al., 1995) 
1.2.5.3 Cytogenetic techniques  
Currently many techniques have been optimised for use in biodosimetry. The 
gold standard still remains the dicentric chromosome assay (DCA) which 
makes use of FISH technique but other techniques include the γH2AX foci 
detection assay, cytokinesis-blocked micronucleus (CBMN) assay and comet 
assay. The table below gives an overview of the studies endorsing the 










The gold standard for 
radiation biodosimetry. An 
established biomarker for 
ionising radiation.  
Finnon et al. 1995; 1999; 
Jovicić et al. 2010; Hoffman 
and Schmitz-Feuerhake, 
1999; Fucić et al. 2007; 
Loucas et al. 2004. Liu Q et 
al. 2010; 
CBMN assay An established bio-marker for 
ionising radiation. There is a 
linear relationship between 
dose of radiation and 
micronuclei (MN) induced, but 
not radiation specific.  
Thierens and Vral, 2009; 
Rossouw et al. 2005; Eken et 
al, 2010; Fennech 2010; Cho 




A component explored as bio-
marker. Each focus formed 
indicates an individual DSB. 
There is data that shows a 
linear relationship between 
dose and induction of foci, but 
not radiation specific. 
Rothkamm and Lobrich, 
2003; Sedelnikova et al. 
2003; Markova et al, 2007; 
Mah et al. (2010); Bhogal et 
al. 2010;  
 
An important factor to take into consideration is the logistics involved. In case 
of a population exposed to unknown doses, it is important to make decisions 
in a few hours. Medical management will need rapid discrimination between 
patients who do and do not need medical treatment. Patients will be 
examined and the first indicators will be their physical symptoms, clinical 
history and location during the accident (Romm et al., 2011). Biodosimeters 
will only give information in the first few days after the accident and can help 
in patient stratification according to the severity of exposure (Hrdina et al., 
2009).  
1.2.5.3.1 Classical biodosimetry techniques 
Dicentric Chromosome assay (DCA). Among radiation-induced chromosome 
aberrations, multicentric chromosomes are considered to be sensitive and 
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specific biomarkers for assessing the radiation dose. In case of accidental 
exposure to radiation, the current dose estimation screening is done using 
dicentric chromosome assay (DCA). DCA has been deployed in several 
radiation accidents involving big populations such as Chernobyl, Goiania and 
Fukushima Daiichi Nuclear power plant accident and still has been the most 
reliable method during radiation emergencies (Ramalho and Nascimento, 
1991, Sevan'kaev, 2000, Suto et al., 2013). DCA is extremely sensitive since 
dicentric chromosomes are almost exclusively induced by ionising radiation 
and is therefore an excellent indicator for dose estimation for radiation 
exposure (Savage, 1998, Flegal et al., 2012). The frequency of dicentrics 
follows a dose-dependent response up to 5 Gy (IAEA, 2001). The drawback 
of the method is that it is time consuming and labour intensive (Romm et al., 
2011). The original protocol included the analysis of 500-1000 metaphases 
(Wilkins et al., 2008). In case of a mass casualty event it has been reduced to 
scoring only 50 metaphase spreads, which has been proven sufficient to 
make an estimation for the guidance of medical treatment (Lloyd, 1997, 
Voisin et al., 2001). Furthermore, dose response curves constructed by in 
vitro irradiation correlate well with in vivo radiation exposures (Bauchinger, 
1998, Durante et al., 2001).  
A variation of the DCA is the analyses of the metaphase cells with the use of 
single stranded probes which contain fluorescence labels. For this purpose, 
the cells need to be arrested in the metaphase which takes minimal 48 hours 
after blood samples have been taken. FISH using Peptide Nucleic Acid (PNA) 
labelled probes can be designed for specific regions. The PNA probes are 
similar to DNA or RNA probes but do not have any charge, therefore the 
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binding with the DNA is stronger and more stable (Paulasova and Pellestor, 
2004). For the analysis of chromosomal aberration, probes complementary to 
telomeric region labelled with Cy3, and probes complementary to the 
centromeric region labelled with FITC are used. PNA staining is effective in 
the detection of chromosomal aberrations such as changes in chromosome 
number (aneuploidy), chromosome fusions, SSBs, DSBs and telomere loss 
which may all lead to genomic instability (Hayata et al., 2001, Sasaki et al., 
2001). Radiation produces both simple translocations and dicentric 
chromosomes, as well as complex chromosomal aberrations (Blakely et al., 
2001). The complexity of the chromosome aberrations becomes more 
apparent at higher doses of ionising radiation (Finnon et al., 1995), thus 
indicating that at low doses the chromosome aberrations seen are less 
complex such as dicentrics and ring chromosomes. However, some studies 
using multicolour-FISH have shown that even low doses of radiation are 
capable of inducing complex aberrations that require at least four breaks for 
their formations (Loucas et al., 2004). 
Genomic instability resulting from radiation exposure is defined as the 
manifestations of genetic damage in a certain fraction of irradiated cells over 
many cell cycles after they were irradiated (Little, 2003). This persistent 
instability is expressed as chromosomal rearrangements, chromosomal 
bridge formations, chromatid breaks and gaps, and micronuclei (MN) 
formation (Limoli et al., 1997) in the progeny of cells that survive irradiation. 
Damage and/or error prone repair of DNA seems to be involved in radiation-
induced genomic instability because mutant cells deficient in the repair 
enzymes needed for non-homologous end joining (NHEJ) pathway is the 
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most sensitive to the induction of radiation-induced and DNA double strand 
breaks induced genomic instability (Little, 2003, Difilippantonio et al., 2002).  
Cytokinesis blocked micronuclei assay (CBMN).  
Cytokinesis blocked micronuclei (MN) assay is one of the most studied 
techniques for its potential in biodosimetry. This technique has an advantage 
over the dicentric assay that the scoring is easier and can be automated 
(McNamee et al., 2009). The CBMN assay has been suggested to be used as 
biodosimeter by the International Atomic Energy Agency. The main drawback 
of the technique is that the cells need to undergo one cell cycle, therefore the 
initial time to get cells in a binucleated cell state is at least 72 hours and the 
effects on DNA damage levels identified by this technique are not specific to 










Schematic diagram of micronucleus formation in a cell. Micronuclei act 
as a measure of genomic integrity. Irreparable DNA damage or lagging 
chromosomes during cell division are excluded from the main nucleus to form 
micronuclei (Fenech, 2007). 
 
Micronuclei (MN) are small bodies in the cytoplasm, resembling the nuclear 
material in morphology and staining pattern. They are formed when a broken 
chromosome or chromosome fragment fails to travel to the spindle during 
mitosis and therefore not included in either daughter nuclei. The MN 
frequency can be quantified using the CBMN assay. This assay has been 
accepted as a standard biodosimeter for radiation exposure and has been 
thoroughly validated and standardised (Fenech, 2007, Thierens and Vral, 
2009). Increased frequency of MN may be considered as a biomarker of 
permanent genotoxic damage. It has been shown that MN formation in 
lymphocytes after exposure to low dose gamma radiation is dose-dependent 
and CBMN assay is a robust biodosimeter at low dose radiation exposure 
(Vral et al., 2011). 
The original CBMN assay is used to observe MN (Figure 5) but has since 
developed into a comprehensive ‘cytome’ system for measuring DNA 
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damage, cytostasis and cytotoxicity (Fenech, 2007). In this technique besides 
the formation of MN which indicates chromosomal loss or breakage, the 
formation of nucleoplasmic bridges (NPBs) which indicate misrepair or 
telomere fusion and nuclear buds (NBUDs) which indicates elimination of 
amplified DNA and DNA repair complexes (Figure 6) are recorded. The 
cytostasis effect can be identified after analysis of the proportion of mono-, bi- 
and multi- nucleated cells and cytotoxicity depends on the levels of necrotic 
and apoptotic cells (Fenech, 2007). By including these biomarkers in the 
technique, it increases the understanding and fate of the cells. Therefore 
CBMN cytome has been acknowledged as biodosimeter which can give 
valuable information which can help to make a reliable dose estimation after 














Various possible fates of cultured cytokinesis-blocked cells following 
exposure to genotoxic events like exposure to ionising radiation. By 
identifying different biomarkers in the CBMN method, more information can 
be obtained from the same samples (Fenech, 2007). 
 
 Gamma H2AX Staining. Ionising radiation induces DNA damage either by 
directly attacking DNA and forming DSBs or via production of ROS. DSB 
formation leads to recruitment of proteins involved in radiation damage repair 
(Figure 7) (Bekker-Jensen et al., 2006). It was shown that ATM-Kinase is the 
first protein to be localised at the DSB (Lavin et al., 1995). Subsequently 
ATM-kinase phosphorylates Serine 139 of H2AX, a subclass of eukaryotic 
histone protein (Rogakou et al., 1998, Fernandez-Capetillo et al., 2004). 
Many studies have used a fluorescent antibody specific for the 
phosphorylated form of H2AX (γH2AX) to visualise the DSBs produced 
following DNA damage. Therefore, γH2AX was used to quantify the formation 
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Phosphorylation events in the initiation of HR. γH2AX is commonly used 
as a marker for early detection of DSBs and the activation of DNA repair. 
ATM-kinase phosphorylates H2AX, which is followed by the activation of DNA 
repair by HR pathway (Summers et al., 2011). 
 
The foci can be detected minutes after irradiation with use of fluorescent 
microscopy. It was reported earlier that H2AX foci reach peak at 30 minutes 
post-irradiation (Sedelnikova et al., 2003). Following a short plateau phase of 
approximately 1 hour, the number of foci decreases with a half-life of several 
hours, due to the various repair mechanisms (Keogh et al., 2006).   
1.2.5.3.2 Genetic assays 
In a scenario where large populations are exposed to radiation, management 
of the crisis would be cumbersome as there is no way to determine the dose 
to which the population has been exposed. The conventional biodosimetry 
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techniques discussed before are time consuming and labour intensive. Even 
though these assays are well established biomarkers for radiation exposure, 
in case of mass casualties, the use of these assays may prove to be harmful 
to the individuals exposed to high doses that would require impromptu 
medical attention. Hence there is a need for efficient and effective biomarkers 
and approaches to dosimetry in order to assign the individuals with significant 
exposure as soon as possible to appropriate medical care.  
Gene expression profiling seems to be promising in this case. By identifying 
specific genes as markers, a screen for that marker would enable faster 
identification of individuals that require immediate medical attention. 
Technological advances in genomics have helped in determining many 
radiation-sensitive biomarkers. Many studies have shown that microarray or 
molecular approaches such as gene expression profiles can be used as 
putative biodosimeters.  Most such approaches have used peripheral blood 
as it is easily accessible and radiation-sensitive. Gene expression has 
measured in whole blood (Blakely et al., 2001, Grace et al., 2003, Paul and 
Amundson, 2011), isolated lymphocytes (Amundson et al., 2000, Dressman 
et al., 2007, Meadows et al., 2008, Miller et al., 2002, Turtoi et al., 2008) or T-
cells (Mori et al., 2005, Mori and Desaintes, 2004). The complex kinetics, 
multiple parameters and the inter-individual variance make it difficult to 
compare and interpret these studies. 
All the above mentioned techniques are being used at the moment to 
estimate dose-rate effect of gamma radiation. So far there is no study using a 
combination of the classical cytogenetic techniques with gene expression 
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profiling in the same set of healthy donors. By comparing the results of the 
classical cytogenetic assays, protein markers and with gene expression 
profiles in ten different individuals, we are able to indicate a set of signature 
marker genes which could be used to complement current biomarkers of 
gamma radiation exposure. We planned to analyse chromosomal instability, 
DSBs, DNA repair efficiency and gene expression at five different doses. By 
using the same donors for all these experiments, we hope to get a better 
understanding of the mechanism behind the effects to exposure of gamma 
radiation. The difficulty in implementing the classical cytogenetic techniques 
for biodosimetry purposes could be overcome by using molecular biomarkers. 
Therefore, it would be useful to identify gene expression patterns which allow 
us predict the dose of exposure. This would allow us to perform high-






In order to identify biomarkers of radiation exposure in human peripheral 
blood lymphocytes, we set out to achieve the following objectives: 
1) Examination of the levels of cytogenetic damage in human 
lymphocytes exposed to various doses (0 to 1.0 Gy) of gamma 
radiation. 
2) Generation of gene expression profiling at 2 and 24 hours post 
irradiation in the same samples as in objective 1. 
3) Analysis of the cytogenetic damage and gene expression changes in 
human lymphocytes exposed to different doses of carbon and iron 
heavy ions.  
In the current study, we aim to gain better insights into the spectrum of effects 
of low dose radiation on cells, which is important for radiation protection and 
in the search of biomarkers. Human blood lymphocytes from healthy donors 
were isolated and irradiated with low doses (0.10 -1.0 Gy) of different types of 
radiation. The results of classical cytogenetic assays were combined with 
molecular assays to elucidate the functional relevance of early biomarkers of 
radiation exposure. Levels of DNA damage, DSB and chromosomal 
aberrations were measured and compared among donors. Biomarkers or 
signature genes in various donors were screened using microarray to provide 





Materials and methods  
2.1 Isolation of human peripheral blood 
lymphocytes 
Buffy coats obtained from ten consenting healthy donors from the Blood Bank 
at National University Hospital (NUH, Singapore NUS IRB Reference code 
07-001, Approval number NUS-280), were diluted three times with 1 x 
Phosphate Buffered Saline (PBS), carefully layered onto Ficoll-HypaqueTM 
(GE Healthcare, Singapore) gradient (density – 1.077 g/litre) and centrifuged 
at 2000 rpm (900 x g), 18°C for 30 minutes. Peripheral Blood Mononuclear 
Cells (PBMCs) accumulate at the top of the Ficoll-Hypaque layer due to their 
lower density. In contrast, red blood cells and granulocytes collect at the 
bottom of the Ficoll-Hypaque layer due to their higher density. The PBMC 
layer above the Ficoll-Hypaque layer was gently aspirated, and washed with 1 
x PBS and centrifuged at 1200 rpm for 10 minutes.  
The PBMCs were then washed with complete Roswell Park Memorial 
Institute-1640 (RPMI-1640) (Gibco, USA) medium, and then suspended in 
RPMI-1640 culture medium supplemented with 10% Fetal Bovine Serum 
(FBS) and 1% penicillin-streptomycin, incubated in T75 culture flasks at 37°C 
in 5% carbon dioxide in a water saturated atmosphere overnight to allow 
monocytes to adhere to the bottom of the flasks. 
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Taking care so as not to agitate the attached monocytes, the medium which 
contains lymphocytes was carefully removed and centrifuged at 1200 rpm, at 
25°C for 10 minutes. The cells were re-suspended in 22.5 mL of complete 
RPMI-1640 culture medium, counted using a haemocytometer and viability 
determined by Trypan Blue exclusion prior to any experiments. These cells 
were then subjected to radiation experiments. 
2.2 Gamma irradiation 
The peripheral blood derived lymphocytes were exposed to gamma radiation 
(source: 137Caesium) at a dose rate of 1.16 Gy/minute (Gammacell 40 
Exactor, Department of Radiation Oncology, National Cancer Institute of 
Singapore, Singapore). The doses used were 0.1 Gy, 0.25 Gy, 0.5 Gy and 1 
Gy. A set of unirradiated cells was maintained in identical conditions as that of 
irradiated cells as control. 
After irradiation, 1.5 mL of cell suspension was kept in culture in PB Karyo 
Max (Gibco, USA) for CBMN Assay and 3.5 mL was kept in culture in PB 
Karyo Max for chromosome preparation. PB Karyo Max contains 
phytohaemagglutinin (PHA), which stimulates mitogenesis. The rest of the 
cell suspension was maintained in the same culture condition. 
Two time points post-irradiation were selected – 2 hours and 24 hours for 
γH2AX assay and microarray gene chip analysis. At two hours post-irradiation 
1.0 mL cell suspension was taken from the flasks for these two assays and 
the remaining cell suspension was left in culture until the 24 hour time point. 
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The cells were spun down and resuspended in 2 mL of fresh media. Fifty 
microliters of cell suspension was then diluted with 50 µL 1 x PBS and used 
for γH2AX foci assay. The remaining cell suspension was centrifuged to get a 
pellet for RNA extraction. The same steps were followed for the 24 hours 
post-irradiation time point. 
2.3 Heavy ion radiation 
Whole blood samples were used in heavy ion exposures. The cells were 
irradiated with two different ion species, carbon (290 MeV/u, LET 70 
keV/micron) and iron (500 MeV/u, LET 200 keV/micron) ions accelerated by 
Heavy Ion Medical Accelerator at National Institute of Radiological Sciences, 
Chiba, Japan. The doses used were 0.1 Gy, 0.25 Gy, 0.5 Gy and 1 Gy. A set 
of unirradiated cells was maintained in identical conditions as that of 
irradiated cells as control. All irradiations were carried out at room 
temperature. 
2.4 γH2AX foci detection by immunofluorescence 
This assay was performed on both – the cells incubated for 2 hours as well as 
those for 24 hours. As lymphocytes are suspension cells, they were fixed onto 
the slide using cytospin at 8500 rpm for 10 minutes. The cells were then fixed 
with 4% (v/v) formaldehyde: 1 x PBS, washed in 1 x PBS, treated with 0.25% 
Triton-X 100 (Biorad Co., USA): 1 x PBS, blocked in 5% BSA for 1 hour then 
incubated with primary monoclonal γH2AX antibody (anti-phospho-H2AX 
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(Ser139, Millipore, USA) diluted with 1% BSA (1:300), for 1 hour at room 
temperature. Unbound antibody was removed by washing with 1 x PBS three 
times for 10 minutes each. The slides were then treated with secondary 
antibody conjugated with fluorescein isothiocyanate (FITC, Santa Cruz 
Biotechnology, USA) diluted with 1% BSA (1:600) at 37° C for 1 hour. The 
slides were once again washed thrice in 1 x PBS for 10 minutes each, and air 
dried. The slides were counter stained for DNA using slow fade 4 µg/mL 4’6-
diamidino 2-phenylindole (DAPI, Vectashield, UK). The images were captured 
using Zeiss Axioplan 2 imaging fluorescence microscope (Carl Zeiss, 
Germany) with FITC and DAPI filters. Fifty cells were analysed and the 
number of foci per cell was recorded. Student's t-test and one-way (one 
factor) ANOVA tests were used for statistical analysis of the data. 
2.5 Cytokinesis-Blocked Micronucleus (CBMN) 
assay 
After irradiation, the cells were incubated in fresh PB Karyo Max for 72 hours. 
The protocol used was adapted from our previous publications (Hande et al., 
1999, Hande et al., 1996). After 44 hours, 4 µg/mL Cytochalasin-B (Sigma-
Aldrich, USA) was added to the culture, and incubated for 28 hours. The cells 
were then harvested and centrifuged at 1200 rpm for 10 minutes. The pellet 
was resuspended and treated with 5 mL of 0.075M potassium chloride (KCl) 
hypotonic solution to aid the swelling of cells, then centrifuged immediately at 
800 rpm for 8 minutes. Subsequently the cells were fixed using a combination 
of Carnoy’s fixative (acetic acid/methanol, 1:3) and three to four drops of 
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formaldehyde. Formaldehyde helps in fixing the cytoplasm and thus, prevents 
it from breaking. The cells were fixed in Carnoy’s fixative twice more without 
formaldehyde. The cells were stored at 4°C for 3-4 days. These aged fixed 
cells were then dragged on clean, dry slides and heat fixed. The cytoplasm 
and nuclear material were differentially stained orange/red and yellow/green 
respectively with 30 µg/mL acridine orange. One thousand binucleated cells 
were scored for the presence and frequency of MN in each sample. Small 
nuclear bodies were counted as MN only if the size was between 1/16-1/3 of 
the daughter nuclei and the colour was of the same intensity as that of the 
daughter nuclei (Fenech, 2007). Zeiss Axioplan 2 imaging fluorescence 
microscope (Carl Zeiss, Germany) was used for scoring the MN. All the 
reagents were from Merck, Germany. Student's t-test and one-way (one 
factor) ANOVA tests were used for statistical analysis of the data. 
2.6 Chromosome preparation 
After irradiation, the cells were allowed to grow in fresh PB Karyo Max 
medium for a total of 70 hours. After 66 hours, cells were treated with 0.1 
µg/mL Karyomax colcemid solution (Gibco, USA) to arrest them at 
metaphase. The cells were then harvested at 70 hours of culturing and 
treated with pre-warmed 0.075 M KCl at room temperature for 14 minutes and 
then centrifuged at 1000 rpm for 10 minutes. Thereafter, the cells were fixed 
with two changes of Carnoy’s fixative followed by centrifugation at 1000 rpm 
for 8 minutes. Metaphase spreads were dropped from a height on clean, dry 
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slides and heat fixed for 15 minutes at 60°C. The slides were aged overnight 
at room temperature, allowing the chromosomes to flatten.  
2.7 Peptide Nucleic Acid- Fluorescence In Situ 
Hybridisation (PNA-FISH) 
The slides that were prepared were used for PNA-FISH (Hande et al., 1999). 
The slides were treated with 1 x PBS to re-hydrate the cells. This was 
followed by fixation in 4% (v/v) formaldehyde (Merck, Germany) and 1 x PBS 
wash step. After washing the slides in 1 x PBS, the slides were subjected to 
0.1 mg/mL pepsin (Sigma, Germany) treatment at 37°C for 2 minutes. Pepsin 
acts by partially digesting the proteins and histones that might interfere in 
hybridisation and also by clearing any debris on the slide. The slides were 
fixed again in 4 % (v/v) formaldehyde. This was followed by another round of 
washing with 1 x PBS. The slides were dehydrated in ethanol (Merck, 
Germany) series (70%, 90% and 100%), and were air dried. Hybridisation Mix 
was prepared with 0.5 µg/mL telomere-specific PNA probe labelled with Cy3 
(Panagene, South Korea) and 3 µg/mL centromere-specific PNA probe 
labelled with FITC (Panagene, South Korea).  Twenty microliters of 
hybridisation mix was applied to each slide on 22 x 60 mm coverslips (Fisher, 
USA). These slides were denatured at 80°C for 3 minutes, and then left for 
hybridisation in a humidified chamber at room temperature for 2 hours. The 
excess probe was then washed off and the slides were dehydrated once 
again in ethanol series (70%, 90% and 100%). Thereafter, the slides were 
allowed to air dry in the dark. Chromosomes were counter stained with 4 
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µg/mL DAPI. Metaphases were captured using Zeiss Axioplan 2 imaging 
fluorescence microscope (Carl Zeiss, Germany). The analysis was done 
using the in situ imaging software (ISIS, MetaSystems, Germany). Telomere 
(Cy3) and centromere (FITC) fluorescence signals were detected and 
checked for the occurrence of breaks: double minutes, acentric and centric 
fragments, chromosome breaks, undetected telomeres, and fusions: dicentric, 
tricentric and ring chromosomes. A minimum of fifty metaphase spreads were 
analysed per sample.  
2.8 Chromosome analysis by multicolour 
Fluorescence In Situ Hybridisation (mFISH) 
The slides that were prepared following chromosome preparation (as 
mentioned above in 2.6) were used for mFISH (Speicher et al., 1996). 
Chromosome paints were obtained from MetaSystems, Germany. The slides 
were treated with 0.1 x SSC to re-hydrate the cells. This was followed by 
denaturation in 2 x SSC at 70°C for 30 minutes after which the solution was 
let to cool down to 37°C. After denaturation the slides were washed in 0.1 x 
SSC and 0.07N NaOH at room temperature, followed by wash steps in 0.1 x 
SSC and 2 x SSC at 4°C. The slides were dehydrated in ethanol (Merck, 
USA) series (70%, 90% and 100%), and then air dried. The probe cocktail 
was placed in a heat resistant PCR tube and denatured separately (75°C for 
5 minutes, 10°C for 30 seconds, 37°C for 30 minutes). The slides were 
incubated with 7µl probe cocktail on a 22 x 22 mm coverslip which was 
sealed with rubber cement and then left for hybridisation in humidified 
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chamber at room temperature for 72 hour incubation period. Post 
hybridisation washing was done in 1 x SSC at 75°C for 5 minutes after 
removing the coverslips. Slides were incubated with detection 1+3 reagent to 
detect Cy5 which is indirectly labelled. Slides were washed in 4 x SSCT for 5 
minutes and PBS for 1 minute. Then, the slides were dipped in distilled water 
and air dried. Chromosomes were counterstained with 4 µg/mL antifade DAPI 
and covered with a 24 x 26 mm coverslip (Fisher, USA). Metaphases were 
captured using Zeiss Axioplan 2 imaging fluorescence microscope (Carl 
Zeiss, Germany) with an HBO-103 mercury lamp and filter sets for FITC, 
Cy3.5, Texas Red, Cy5, Aqua and DAPI. Images were captured, processed 
and analysed for the chromosomal instability using the in situ imaging 
software Isis (Metasystems, Germany). A minimum of fifty metaphase 
spreads were analysed per sample. In the mFISH technique all 46 
chromosomes (1-22, X and Y) are each painted in a different colour using 
combinatorial labelling. Therefore this technique is used to detect 
interchromosomal translocations which can be observed as colour junctions 
on individual chromosomes. 
2.9 RNA extraction 
Cells were pelleted by spinning at 5000 rpm for 5 minutes. Total RNA was 
extracted from using QIAmp RNA Blood Mini Kit (Qiagen, Germany) 
according to manufacturer’s instructions. The cells were lysed using Qiazol 
lysis solution, homogenized with chloroform, mixed with 525ul 100% Ethanol 
and applied to RNeasy spin column for absorption of RNA to the column 
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membrane. A wash with RW1 was then carried out. Thereafter another RW1 
wash and 2 washes with RPE were carried out before eluting with RNase-free 
water. Extracted RNA was quantified using NanoDrop 1000 (Thermo 
Scientific, USA).  RNA integrity was checked using Bio-Analyzer (Agilent 
Technologies, USA). An RNA Integrity Number (RIN) greater than 7 indicates 
that the RNA integrity was considered good.  
2.10 Genome-wide gene expression microarray 
analysis 
From each sample, 500 ng of extracted RNA was first reverse transcribed to 
cDNA, which was then transcribed to yield biotinylated cRNA using TotalPrep 
RNA Amplification Kit (Ambion, USA) according to the manufacturer’s 
instructions. cRNA was purified and 750 ng of this cRNA hybridised to 
HumanRef 8.0, v3.0, Human Whole-Genome Expression BeadChips, 
(Illumina, USA) for 16 hours at 58°C. Thereafter the arrays were washed and 
stained with Streptavidin-Cy3 (GE Healthcare, UK). Illumina BeadArray 
Reader was used to scan the arrays according to the manufacturer’s 
instructions. The array data obtained after scanning was imported and 
analysed using Partek® Genomics SuiteTM (Partek, USA).  
Principal component analysis was performed before the analysis quality 
control purposes. Each dose was compared with non-irradiated controls, 
separately for 2 and 24 hours, by paired t-test (Student’s t-test) with an 
unadjusted p-value less than 0.05, and then the overlapping genes among all 
 41 
 
doses for each time point were chosen. Further, the list of significantly 
deregulated genes from 2- and 24-hour time points were pooled. 
Unsupervised two-dimensional average-linkage hierarchical clustering of the 
differentially expressed genes was performed using Spearman’s correlation 





Biomarker identification following exposure 
to gamma radiation 
3.1 Background 
Despite the wealth of data showing effects of gamma radiation at various 
doses, the effects of exposure to low doses of gamma radiation is still poorly 
understood. It has been shown that exposure to high doses of radiation 
induces DNA damage and results in apoptosis, autophagy and senescence; 
but controversy still exists regarding the effects of exposure to low dose 
radiation (Aleta, 2009). Whether the linear no-threshold model (LNT) – which 
means that even a very low dose is genotoxic and will thus increase lifetime 
cancer risk – holds true; or whether low doses might, on the contrary, have a 
protective effect called hormesis – where low doses of ionising radiation is 
thought to be protective as it stimulates the activation of DNA repair 
mechanisms – proves to right, is still unclear (Preston, 2008, Szumiel, 2012).  
The identification of effects of exposure to low dose gamma radiation is of 
great interest because of several aspects. Low dose radiation exposure has 
shown to increase cellular DNA damage and cancer risks (Nguyen and Wu, 
2011). However it is questionable if this is due specifically to radiation 
exposure, as the background effects of non-radiation induced DNA damage 
might have a significant influence (Pollycove and Feinendegen, 2003). 
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Therefore, biodosimeters need to be extremely sensitive and specific to 
radiation to provide meaningful information about low dose exposures.  
In case of a mass causality event, the initial concern is about immediate 
medical needs of patients exposed to relatively high doses of radiation. In this 
phase, biodosimeters that can give rapid dose estimation are required. In the 
aftermath of the event, the long-term health effects and potential heritable 
effects in the offspring of the survivors become important (Wakeford, 2004). 
Some biomarkers can only be detected within a few hours after exposure, 
while other markers can persist for years (Rana et al., 2010). Therefore the 
usefulness of biodosimeters depends on the characteristics of the biomarker 
and the logistics available at the time of the event. 
3.2 Results 
We sought to determine different characteristics of cells exposed to low doses 
of gamma radiation on the same set of samples. This will help to compare the 
reliability and specificity of different biomarkers. In order to identify the 
difference in biomarkers, we set out to evaluate cytogenetic indicators and 
γH2AX, as well as analyse gene expression profiles to find potential, specific 
differentially regulated genes upon irradiation of human peripheral blood 




3.2.1 Evaluation of H2AX foci as biomarker of exposure 
to gamma rays   
For this study, irradiated and control lymphocytes were processed at two time 
points, 2 and 24 hours post irradiation. Cells were attached to slides with the 
use of the cytospin as previously described. Immunostaining with antibody 
against γH2AX was used for the measurement of DSBs related to DNA 
damage and repair mechanisms and compared to basal levels (Figure 8). 
The first 50 cells were observed for the occurrence of γH2AX foci.  
A dose-dependent increase in DSBs was observed two hours post-irradiation 
in all the 10 donors (Figure 8D), with an average basal level of 0.12 γH2AX 
foci per cell and an average of 4.49 γH2AX foci per cell after exposure to 1.0 
Gy. This confirms that there is a significant correlation between dose of 
exposure and DSBs formation which is in agreement with previous findings 
(Wang et al., 2014). Twenty four hours post irradiation, levels of DSBs are 
reduced almost back to control levels with an average of 0.28 γH2AX foci per 
cell after exposure to a dose of 1.0 Gy (Figure 8D). This implies that DSBs 
are efficiently removed or repaired, which confirms that DNA repair 
mechanisms are activated. Since H2AX staining showed a dynamic 
response over 24 hours, we sought to investigate multiple end points and 
more cytogenetic abnormalities induced by low dose radiation exposure 






                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
 
            
Figure 8 
H2AX foci following gamma radiation as a measure of inflicted DNA double strand breaks in human lymphocytes. A-D. Post 
irradiation processing was done at two time points, 2 and 24 hours to understand the kinetics of DNA DSBs and decay of H2AX foci.  
Images of fixed human lymphocytes (counter stained with DAPI) show H2AX foci (stained with FITC in green) as revealed by 
fluorescence microscopy. At least 50 cells were analysed for each condition. Representative of immunofluorescence images of 
H2AX A. without radation exposure; B. 2 hours after exposure to different doses (0.1-1.0 Gy) gamma rays; C. 24 hours after 
exposure to different doses (0.1-1.0 Gy) of gamma rays; D. Kinetics of H2AX foci formation follow a dose-dependent pattern 2 hours 
post irradiation whereas the foci reach basal level at 24 hours after irradiation. 
Data is represented as mean, One-way ANOVA was performed to assess statistical analysis. 
* P < 0.05, where significance is calculated to non-irradiated control cells 
** P < 0.01 where significance is calculated to non-irradiated control cells 





3.2.2 Assessment of micronuclei as a potential 
biomarker of gamma radiation exposure 
The effect of gamma radiation on genomic integrity was measured by the 
level of MN formation. Cells that completed a single nuclear division following 
irradiation were arrested at cytokinesis with cytochalasin B to yield 
binucleated (BN) cells. BN cells from each sample were scored for the 
presence and distribution of MN. The summary of the MN frequency 
expressed as the percentage of BN cells with MN, and the percentage of total 
MN per 1000 BN cells are collated in Table 3-4. Examples of BN cells with 
and without the presence of MN captured with Axioplan 2 image fluorescent 
microscope (Carl Zeiss, Germany) with a triple-band filter are shown in 
Figure 9. 
We detected an average basal level of 8 MN in 1000 BN cells with no 
significant difference between the control cells (Table 3-4) which is consistent 
with previous reported levels of normal human lymphocytes that were not 
exposed (Fenech and Bonassi, 2011). We observed an overall dose-
dependent increase in MN with increasing radiation dose (p<0.0001) with an 
average of 79 MN in 1000 BN cells after exposure to 1 Gy gamma radiation 
(Figure 9B-D). We also detected an increase in variation among the ten 
different donors with increasing radiation dose (p<0.05) which supports our 
hypothesis that there is variation in individual radiation susceptibility which 





              
       
 
Dose (Gy) Total BN scored 
BN with number of MN 
 
BN with MN Total MN 
  1MN 2MN   
        
  







 0.0 1000 7 0 
 
7 7 
0.1 1000 21 0 
 
21 21 
0.25 1000 38 0 
 
38 38 
0.5 1000 44 3 
 
47 50 
1.0 1000 64 1 
 
65 66 
              







 0.0 1000 8 0 
 
8 8 
0.1 1000 24 1 
 
25 26 
0.25 1000 27 0 
 
27 27 
0.5 1000 31 3 
 
34 37 
1.0 1000 43 4 
 
47 51 
              







 0 1000 10 1 
 
11 12 
0.1 1000 24 2 
 
26 28 
0.25 1000 35 3 
 
38 41 
0.5 1000 38 2 
 
40 42 
1 1000 65 1 
 
66 67 
              







 0 1000 11 0 
 
11 11 
0.1 1000 27 4 
 
31 35 
0.25 1000 34 5 
 
39 44 
0.5 1000 50 5 
 
55 60 
1 1000 79 5 
 
84 89 
              







 0 1000 12 0 
 
12 12 
0.1 1000 13 0 
 
13 13 
0.25 1000 22 2 
 
24 26 
0.5 1000 46 4 
 
50 54 
1 1000 86 10 
 
96 106 
              







 0 1000 8 0 
 
8 8 
0.1 1000 11 0 
 
11 11 
0.25 1000 25 0 
 
25 25 
0.5 1000 24 2 
 
26 28 
1 1000 65 9 
 
74 83 
              







 0 1000 9 0 
 
9 9 
0.1 1000 11 2 
 
13 15 
0.25 1000 19 1 
 
20 21 
0.5 1000 36 3 
 
39 42 
1 1000 92 10 
 
102 112 
               







 0 1000 6 0 
 
6 6 
0.1 1000 10 0 
 
10 10 
0.25 1000 31 0 
 
31 31 
0.5 1000 37 5 
 
42 47 
1 1000 64 9 
 
73 82 
              
 










 0 1000 1 0   1 1 
0.1 1000 12 0 
 
12 12 
0.25 1000 24 1 
 
25 26 





1 1000 65 10 
 
75 85 
              








 0 1000 6 0 
 
6 6 
0.1 1000 11 0 
 
11 11 
0.25 1000 15 2 
 
17 19 
0.5 1000 22 2 
 
24 26 
1 1000 49 2 
 
51 53 
               
        Table 3 
Micronuclei (MN) in cytokinesis-blocked lymphocytes of control and 
those exposed to different doses of gamma radiation. Human 
lymphocytes were stimulated by adding PB Karyo Max. Cytokinesis was 
blocked after 44 hours by adding cytochalasin B. The cells were stained with 
acridine orange (30 μg/ml), for each condition 1000BN cells were scored for 










% BN with MN 
 
    




               0.00 0.70 0.80 1.10 1.10 1.20 0.80 0.90 0.60 0.10 0.60 
 
0.79 0.32 
 0.10 2.10 2.50 2.60 3.10 1.30 1.10 1.30 1.00 1.20 1.10 
 
1.73 0.77 
 0.25 3.80 2.70 3.80 3.90 2.40 2.50 2.00 3.10 2.50 1.70 
 
2.84 0.78 
 0.50 4.70 3.40 4.00 5.50 5.00 2.60 3.90 4.20 4.50 2.40 
 
4.02 1.00 




              
 





    
 D1 D2 D3 D4 D5 D6 D7 D8 D9 D10   Average Stdev 
 
               0.00 0.70 0.80 1.20 1.10 1.20 0.80 0.90 0.60 0.10 0.60 
 
0.80 0.33 
 0.10 2.10 2.60 2.80 3.50 1.30 1.10 1.50 1.00 1.20 1.10 
 
1.82 0.88 
 0.25 3.80 2.70 4.10 4.40 2.60 2.50 2.10 3.10 2.60 1.90 
 
2.98 0.85 
 0.50 5.00 3.70 4.20 6.00 5.40 2.80 4.20 4.70 4.60 2.60 
 
4.32 1.07 
 1.00 6.60 5.10 6.70 8.90 10.60 8.30 11.20 8.20 8.50 5.30 
 
7.94 2.04 
                             
 
               Table 4 
A. Percentage of cytokinesis-blocked binucleated cells (BN) with micronuclei (MN). B. Percentage of MN following 
exposure to different doses of gamma radiation. For each condition 1000 binucleated cells were analysed for the presence 
of micronuclei. A. Levels of BN with MN indicated in table 3 were used to calculate percentage of BN with MN B. while levels 
total MN indicated in table 3 were used to calculate percentage of MN. Dose-dependent increase of MN was observed with 
increasing radiation dose, significant difference was observed within different donors. Two way ANOVA was performed to 









Cytokinesis Blocked Micronucleus (CBMN) assay for measurement of 
DNA damage induced by gamma irradiation. Example of binucleated 
human lymphocyte A. without and B. with micronuclei. The white arrow (B) 
indicates the micronucleus formed among the binucleated cells. Cells and 
nuclei were stained with acridine orange (30 μg/ml). Magnification = 63×. C. 
Scatter plot representing percentage of BN cells that contain MN scored 
following low dose gamma radiation in human lymphocytes. D. Percentage of 
MN in 1000 BN cells. Dose-dependent increase of MN was observed with 
increasing radiation dose but significant difference was also observed within 
different donors. Two way ANOVA was performed to assess statistical 









3.2.3 Analyses of chromosomal aberrations and 
dicentric formation following gamma radiation exposure 
for potential as biomarkers 
Cytogenetic experiments were performed to compare genomic instability in 
human lymphocytes. FISH with specific fluorescence probes complementary 
to the telomeric and centromeric regions on the chromosomes was employed 
to visualise chromosomes. For this technique, the cells were arrested in the 
metaphase with colcemid as described in Chapter 2 (Section 2.6). PNA 
probes were labelled with a fluorescence tag, Cy3 (red) for telomeric region 
and FITC (green) for centromeric region. By staining centromeric and 





chromosome fusions, SSBs, DSBs, telomere loss and changes in 
chromosome number (aneuploidy) which can eventually lead to genomic 
instability. We observed dicentric formation which was at an average of 9 
dicentrics after exposure to 1 Gy gamma radiation per 100 metaphase cells 
analysed, while none were detected in control non-irradiated samples (Table 
5). Besides the induction of dicentrics, different types of aberrations were 
observed in human lymphocytes after low dose gamma radiation. We 
observed a dose-dependent increase in chromosomal aberrations which was 
on average 36 aberrations per 100 metaphases after exposure to 1 Gy 
gamma radiation as against 1 aberration per 100 metaphases in control cells 
(Figure 10). A similar trend was observed in the percentage of aberrant cells 
which went from 1% in control samples to an average of 21% in sample 
exposed to 1 Gy gamma rays. In addition, we also identified inter-individual 
variation among the donors in all these aspects (Figure 10A-K). Data for total 
aberrations per cell, frequency of DC per cell and percentage of aberrant cells 







Telomere PNA-FISH was used to detect chromosomal aberrations in 
metaphases Cy3-telomere and FITC-centromere PNA probes, depicted by 
red and green signals, chromosomes are counterstained with DAPI. A. 
Metaphase spread from lymphocytes not exposed to radiation showing no 
detectable aberrations. B-K. Representative images depicting different types 
of aberrations observed in lymphocytes exposed to low dose gamma 
radiation. B. Double minute from an interstitial deletion C. An acentric 
fragment from a terminal break D. Centric fragment from an interstitial 
deletion E. Loss of single one telomere signal F,G. Loss of both telomere 
signals H. Dicentric chromosomes from fusion of two chromosomes I. Sister 
chromatid fusions. J. Fusion of two terminal acentric fragments K. Ring 


















Aberrant cells DC (%) 
  







 0 93 0 0 0 0 0 
0.1 100 11 0 11 (0.11/cell) 11 (11%) 0 
0.25 75 12 1 13 (0.17/cell) 10 (13.33%) 1 (0.01/cell) 
0.5 100 18 4 22 (0.22/cell) 14 (14%) 3 (0.03/cell) 
1 100 18 11 29 (0.29/cell) 21 (21%) 11 (0.11/cell) 
                
 







 0 100 0 0 0 0 0 
0.1 100 10 2 12 (0.12/cell) 9 (9%) 1 (0.01/cell) 
0.25 100 19 0 19 (0.19/cell) 14 (14%) 0 
0.5 95 21 3 24 (0.25/cell) 17 (17.89%) 3 (0.03/cell) 
1 100 34 12 46 (0.46/cell) 22 (22%) 9 (0.09/cell) 
                
 







 0 100 0 0 0 0 0 
0.1 100 10 2 12 (0.12/cell) 8 (8%) 0 
0.25 100 19 0 19 (0.19/cell) 16 (16%) 0 
0.5 100 13 4 17 (0.17/cell) 9 (9%) 2 (0.02/cell) 
1 100 22 10 32 (0.32/cell) 21 (21%) 9 (0.09/cell) 
                
 







 0 100 0 0 0 0 0 
0.1 100 9 1 10 (0.10/cell) 10 (10%) 1 (0.01/cell) 
0.25 60 2 0 2 (0.03/cell) 2 (3.33%) 0 
0.5 99 22 6 28 (0.28/cell) 16 (16.16%) 5 (0.05/cell) 
1 100 26 12 38 (0.38/cell) 23 (23%) 10 (0.10/cell) 
                
 







 0 100 2 0 2 (0.02/cell) 2 (2%) 0 
0.1 58 5 0 5 (0.09/cell) 4 (6.90%) 0 
0.25 68 8 3 11 (0.16/cell) 9 (13.24%) 3 (0.04/cell) 
0.5 65 8 2 10 (0.15/cell) 8 (12.31%) 2 (0.03/cell) 
1 50 21 9 30 (0.60/cell) 15 (30%) 9 (0.18/cell\) 
                
 







 0 89 1 0 1 (0.01/cell) 1 (1.12%) 0 
0.1 100 5 1 6 (0.06/cell) 5 (5%) 0 
0.25 77 12 1 13 (0.17/cell) 9 (11.69%) 1(0.01/cell) 
0.5 81 21 4 25 (0.31/cell) 13 (16.05%) 3 (0.04/cell) 
1 59 6 4 10 (0.17/cell) 7 (11%) 4 (0.07/cell) 
                
 







 0 100 1 0 1 (0.01/cell) 1 (1%) 0 
0.1 100 3 1 4 (0.04/cell) 4 (4%) 0 
0.25 100 7 1 8 (0.08/cell) 7 (7%) 1 (0.01/cell) 
0.5 100 22 0 22 (0.22/cell) 14 (14%) 0 
1 100 26 7 33 (0.33/cell) 21 (21%) 5 (0.05/cell) 
                
 







 0 100 5 0 5 (0.05/cell) 4 (4%) 0 
0.1 100 8 1 9 (0.09/cell) 5 (5%) 1 (0.01/cell) 
0.25 100 7 1 8 (0.08/cell) 8 (8%) 1(0.01/cell) 
0.5 100 18 5 23 (0.23/cell) 16 (16%) 3 (0.03/cell) 
1 100 20 10 30 (0.30/cell) 15 (15%) 9 (0.09/cell) 
                
 







 0 100 1 0 1 (0.01/cell) 1 (1%) 0 
0.1 80 24 1 25 (0.31/cell) 17 (21.25%) 0 
0.25 82 21 1 22 (0.27/cell) 16 (19.51%) 1 (0.01/cell) 
0.5 100 9 2 11 (0.11/cell) 10 (10%) 1 (0.01/cell) 
1 100 30 6 36 (0.36/cell) 18 (18%) 6 (0.06/cell) 
                
 








 0 100 1 0 1 (0.01/cell) 1 (1%) 0 
0.1 83 8 0 8 (0.10/cell) 8 (9.64%) 0 
0.25 71 15 2 17 (0.24/cell) 14 (19.72%) 2 (0.03/cell) 
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0.5 64 7 1 8 (0.13/cell) 7 (10.94%) 1 (0.02/cell) 
1 100 27 7 34 (0.34/cell) 24 (24%) 5 (0.05/cell) 






Table 5  
Analysis of chromosomal aberrations in metaphases from human 
peripheral blood lymphocytes after exposure to various doses of 
gamma radiation. At least 50 cells were analysed for each condition. Breaks 
include double minutes; acentric fragments; centric fragments and undetected 
telomeres. Fusions include dicentrics, tricentrics, sister chromatide fusions 
and ring formations. We checked for breaks, fusions, dicentrics and a total of 
all observed aberrations. The percentage of aberrant cells was calculated 
according to the number of metaphases analysed. Dose-dependent increase 
of aberrations and dicentric formations was observed with increasing 
radiation. Two way ANOVA was performed to assess statistical analysis. 
 






Chromosome aberrations observed in human lymphocytes after exposure to various doses of gamma radiation. A. Overview of 
total chromosomal aberrations per analysed cell. B. Frequency of dicentric formations per analysed cell. C. Percentage of aberrant cells 
following gamma radiation treatment, represented as the number of cells carrying aberrations per 100 analysed cells. We observed a dose-
dependent response in chromosomal aberrations, dicentric formation and percentage of aberrant cells after exposure to low doses of 
gamma radiation. Statistical significance between the doses was assessed using two way ANOVA, using Graphpad Prism. The difference 
was considered statistically significant when *P<0.05; **P<0.01 and ***P<0.001. 
 
A B C 
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3.2.4 Multicolour Fluorescence In Situ Hybridisation 
(mFISH) analysis to assess chromosome aberrations 
following gamma radiation exposure  
We performed multi-colour Fluorescence In Situ Hybridisation (mFISH) to 
look for potential repetitive signature of chromosomal aberrations (that can 
serve as biomarkers of exposure); to identify the ratio of reciprocal, non-
reciprocal and complex chromosome translocations; and to evaluate any 
possible chromosomal bias following gamma irradiation. mFISH assay uses 
various fluorescence dyes to visualise each chromosome in a different colour. 
Labelling with a single specific probe or combinatorial labelling results in 
unequivocal colour signature for each chromosome. This allows for the 
detection of numerical and structural aberrations in each metaphase (Figure 
12). From the pool of ten donors, we analysed three randomly chosen 
peripheral lymphocyte samples exposed to 1 Gy gamma radiation and 
compared it with unexposed cells from the same donor. In 26% of the 
analysed metaphase spreads after 1 Gy gamma radiation, we identified non-
reciprocal translocations, in 4.6% – reciprocal translocations, in 1.7% – 
complex translocations and in 20% – other aberrations like breaks and 
deletions (Figure 13). While the occurrence of non-reciprocal translocations 
remained uniform in all the donors assessed following gamma radiation 
exposure, there was a notable difference in the incidence of other aberrations 
– breaks and deletions among the donors. 
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To analyse if certain chromosomes were more susceptible to radiation, we 
tracked down the chromosomes involved in exchanges and aberrations. We 













Chromosomal rearrangements  in human lymphocytes exposed to 1 Gy 
gamma radiation by mFISH. A cell from an irradiated sample, showing a 
non-reciprocal translocation involving chromosome 6 and 8. Metaphases are 
hybridized for 72 hours with mFISH probes with 5 different labels which can 
be detected with fluorescence microscope with the filters: FITC, Cy3.5, Texas 
Red, Cy5, and Aqua. Chromosomes involved in aberrations are indicated by 
arrows. The majority of aberrations were non-reciprocal translocations and 







Ratio of chromosome rearrangements in human lymphocytes after exposure 
to 1 Gy gamma radiation. Non-reciprocal, reciprocal, complex exchanges and 
other aberrations observed using mFISH analysis in three donors chosen 
randomly. Complex exchanges are the result of reconstitution of more than 3 
breaks in at least 2 chromosomes; and the category ‘Others’ includes breaks, 
deletions and duplications.  
 
Figure 14 
Distribution of aberrations in all chromosomes after exposure to 1 Gy 
gamma radiation. Data represents the frequency of occurrence of 
translocations and other aberrations in each chromosome, as analysed using 







3.2.5 Analysis of gene expression profiles for signature 
genes following exposure gamma radiation  
The various cytogenetic and molecular parameters assessed as biomarkers 
of radiation exposure did show potential applications. However, the 
complexity of the kinetics of their production and persistence and lack of 
induction at certain doses, indicates the need for other reliable markers.  
Nonetheless, with the rich contextual information obtained from those studies, 
we set out to analyse genome-wide gene expression profiles following 
gamma radiation exposure in the same samples, in an effort to pull out a 
highly sensitive and reproducible signature that could be deployed as a 
biomarker of exposure. The samples were irradiated with the various doses of 
gamma radiation, microarray was performed and the gene expression profiles 
were analysed. Data was obtained using HumanRef-Expression Bead Chips 
(Illumina) and presented as two-way hierarchical clustering of gene 
expression (Figure 15). While there was no marked difference between the 
gene-expressions of different doses, the expression profiles after 2 hours of 































 Figure 15 
Hierarchical clustering of gene expressions following exposure to various doses of gamma radiation in human lymphocytes. 
Microarray was performed using HumanRef-Expression Bead Chips (Illumina) and the data analysed by Partek Genomics Suite. Overall 
representation of significantly deregulated genes by unsupervised two-way hierarchical clustering. Column, a single sample; row, a single 
gene. Expression levels (red) for up-regulation and (blue) for down-regulation according to the colour scale. While there was no marked 
difference between the gene-expressions of different doses, the expression profiles after 2 hours of post-irradiation was quite distinct 




3.2.6 Principal component analysis mapping of human 
blood lymphocytes following exposure to gamma 
radiation 
Principal component analysis (PCA) gives useful insights into the inner 
workings of the gene expression results displayed by the software. Here, we 
notice that the accountable variation observed in the gene expression in the 
various treatments amounts to about 67%, which is indicative of a highly 
reliable experimental run. The three-dimensional PCA revealed a striking 
pattern of clustering based on post-irradiation time (Figure 16A-C). This 
implies that post-irradiation time is the most influential factor on variation in 
gene expression profiles. Whatever the time following exposure is, gene 
expression profiling with a reliable gene signature in hand could serve as a 








Representative images of principal component analysis of 
various data points, showing no obvious clustering by dose or 
donors, but a striking pattern by time (Partek Genomics Suite was 
used in gene expression analysis). Each sample was coloured based 
on: A. number of donors (D1-D10) B. doses (0-1.0 Gy) and C. post-










We analysed differentially expressed genes after two and 24 hours post-
irradiation (Figure 17). We identified a set of 46 genes (Table 6A), which are 
differentially expressed (p<0.05) in all ten donors exposed to the dose range 
from 0.1-1.0 Gy compared to basal levels 2 hours post irradiation (see 
Chapter 2 Section 2.10 for methodology). We identified a set of 45 genes 
(Table 6B), which are differentially expressed (p<0.05) in all ten donors 
exposed to the dose range from 0.1-1.0 Gy compared to basal levels 24 
hours post irradiation. There are 4 genes overlapping in both the time points – 
2 and 24 hours, meaning these genes, irrespective of the post-irradiation 
times analysed, are differentially expressed in all 80 samples compared to the 
control which are the non-irradiated samples (Table 6C). These genes are 







Venn Diagram of numbers of significantly differential expressed genes following exposure to various doses of 
gamma radiation A. 2 hours B. And 24 hours post irradiation to various doses of gamma radiation. Values within 
parantheses stand for numbers of differentially expressed genes (as analysed using Partek Genomic Suite) for the 
respective dose as compared to unirradiated controls of the same time-point post irradiation. Values within the area enclosed 
by different colours indicate the numbers of differentially expressed genes that overlapped with the circle of intersection. 






0.1 Gy 0.25 Gy 0.5 Gy 1 Gy 
ANKDD1A -1.147 -1.258 -1.135 -1.257 
ANXA5 -1.257 -1.269 -1.265 -1.206 
AQP9 -1.353 -1.414 -1.429 -1.489 
C14ORF80 1.101 1.125 1.117 1.12 
CCL2 -1.34 -1.448 -1.441 -1.368 
CD70 1.293 1.484 1.74 2.174 
CD93 -1.297 -1.64 -1.435 -1.36 
CDC2L2 1.096 1.109 1.166 1.085 
CDKN1A 1.153 1.4 1.693 2.135 
CLEC5A -1.279 -1.354 -1.231 -1.371 
CSF1R -1.338 -1.445 -1.301 -1.267 
DAPK1 -1.202 -1.342 -1.293 -1.187 
DMXL2 -1.256 -1.34 -1.343 -1.293 
EMR2 -1.236 -1.387 -1.265 -1.249 
EPB41L3 -1.334 -1.539 -1.536 -1.405 
ETV3 -1.155 -1.214 -1.208 -1.14 
FLJ20273 -1.311 -1.679 -1.321 -1.237 
GADD45A 1.197 1.262 1.373 1.576 
GBP5 -1.128 -1.319 -1.197 -1.158 
IER3 -1.248 -1.365 -1.292 -1.222 
IL1B -1.354 -1.378 -1.412 -1.467 
IL1RN -1.218 -1.282 -1.265 -1.194 
ISG20L1 2.316 2.835 3.305 3.823 
LRCH4 1.06 1.164 1.143 1.118 
MARCH1 -1.182 -1.332 -1.339 -1.241 
MS4A14 -1.187 -1.311 -1.219 -1.201 
MS4A7 -1.328 -1.582 -1.414 -1.342 
NFKBID 1.118 1.186 1.385 1.48 
NRP1 -1.217 -1.323 -1.252 -1.192 
OR13D1 1.06 1.145 1.108 1.091 
PGCP -1.174 -1.297 -1.265 -1.207 
PID1 -1.289 -1.385 -1.393 -1.458 
RGS16 1.153 1.278 1.577 2.002 
RHOQ -1.229 -1.292 -1.188 -1.207 
S100A4 -1.125 -1.273 -1.224 -1.159 




SESTD1 -1.152 -1.278 -1.249 -1.201 
SLC16A6 -1.229 -1.372 -1.431 -1.502 
SLC22A4 -1.187 -1.309 -1.242 -1.228 
SLC7A11 -1.268 -1.256 -1.211 -1.201 
TGFBI -1.257 -1.615 -1.318 -1.357 
TIMP1 -1.181 -1.401 -1.191 -1.207 
TPM4 -1.111 -1.435 -1.237 -1.2 
VCAN -1.41 -1.838 -1.477 -1.621 




0.1 Gy 0.25 Gy 0.5 Gy 1 Gy 
ACTA2 1.421 1.757 2.098 2.057 
APOBEC3H 1.744 2.352 3.058 3.517 
ASTN2 1.070 1.198 1.230 1.296 
BAX 1.568 2.088 2.463 2.341 
C12ORF5 1.174 1.266 1.370 1.383 
C1ORF110 1.087 1.163 1.179 1.227 
CD19 -1.148 -1.342 -1.277 -1.329 
CD70 1.346 1.728 1.973 2.213 
CD79A -1.151 -1.288 -1.410 -1.538 
CDKN1A 1.242 1.468 1.841 2.013 
CMBL 1.118 1.286 1.448 1.753 
DCP1B 1.132 1.188 1.229 1.228 
DDB2 1.311 1.449 1.844 1.972 
DHDH 1.126 1.235 1.177 1.193 
EDA2R 1.112 1.217 1.152 1.221 
ELAVL4 1.066 1.138 1.064 1.070 
FBXO22 1.069 1.198 1.230 1.219 
GADD45A 1.305 1.632 1.986 2.368 
GLS2 1.060 1.195 1.196 1.271 
GRM3 1.081 1.192 1.152 1.161 
HIST1H2AC 1.179 1.282 1.253 1.164 
HIST1H2BD 1.107 1.181 1.222 1.200 
HIST1H3H 1.067 1.176 1.054 1.127 
ISG20 -1.257 -1.364 -1.663 -1.846 




LIG1 1.182 1.395 1.441 1.562 
LOC90925 -1.153 -1.247 -1.353 -1.603 
MAMDC4 1.199 1.423 1.647 1.783 
MAP4K4 1.134 1.211 1.255 1.238 
PHLDA3 1.216 1.373 1.549 1.700 
PHPT1 1.444 1.596 1.998 1.946 
RN7SK 1.229 1.353 1.368 1.471 
SESN1 1.333 1.602 1.879 1.974 
TCF4 -1.142 -1.287 -1.156 -1.281 
TNFRSF10B 1.521 1.743 2.109 2.200 
TNFRSF10D 1.099 1.298 1.327 1.417 
TNFSF4 1.363 1.651 2.086 2.664 
TNFSF8 1.368 1.631 1.982 2.103 
TNFSF9 1.136 1.210 1.233 1.281 
TRIAP1 1.186 1.513 1.569 1.638 
TRIM22 1.273 1.430 1.666 1.601 
VPREB3 -1.239 -1.408 -1.499 -1.748 
VWCE 1.143 1.252 1.301 1.440 
XKR4 1.076 1.157 1.082 1.069 
XPC 1.347 1.541 1.900 1.972 
 
Gene 
2 hours 24 hours 
0.1 Gy 0.5 Gy 0.25 Gy 1 Gy 0.1 Gy 0.5 Gy 0.25 Gy 1.0 Gy 
CD70 1.293 1.740 1.484 2.174 1.346 1.973 1.728 2.213 
CDKN1A 1.153 1.693 1.400 2.135 1.242 1.841 1.468 2.013 
GADD45A 1.197 1.373 1.262 1.576 1.305 1.986 1.632 2.368 






A. Gene expression profiles 2 hours post gamma irradiation. All changes are 
compared versus control sample; this is done for each donor separately so that each 
donor has its own control levels. The fold change is affected by 10 control samples 
versus 40 irradiated samples. (P<0.05) B. Gene expression profiles 24 hours post 
gamma irradiation. C. Genes differentially expressed after gamma radiation at 2 and 





We observed significant difference in the levels of DNA damage and 
chromosomal aberrations among the 10 donors. This suggests inter-
individual variation after gamma radiation is an important factor to 
include in dosimetry methods. We compared the gene expression 
profile from the donor with the least dicentric formation (donor 7 with a 
percentage of 5% dicentric formation after exposure of 1 Gy gamma 
radiation) versus the donor with highest levels of dicentric formation 
(donor 5 with a percentage of 18% dicentric formation after 1 Gy 
exposure) (Table 5). We found 79 significant, differentially expressed 
genes after 2 hours and 1963 genes after 24 hours post-irradiation 




   
 
Figure 18 
Venn diagram of numbers of significantly differential expressed 
genes between most radiosensitive and most radioresistant 
donor. Venn diagram shows significant (P<0.05) differential 
expressed genes between the least sensitive donor (Donor 7, 5% 
dicentric formation after exposure to 1 Gy gamma radiation) and most 
sensitive donor (Donor 5, 18% dicentric formation after exposure to 1 
Gy gamma radiation).  
 
We identified 55 genes which are differential expressed at both time 
points. Although, validation of these in more extensive studies is 
imperative, these genes could, nonetheless, serve as potential 
markers for radiation sensitivity (Table 7).  
  
24 h (1963) 2 h (79) 




Gene p-value Ratio Fold Change 
HLA-A29.1 1.36E-07 202.996 203.00 
IFIT3 9.99E-07 29.104 29.10 
CXCL10 1.42E-05 17.177 17.18 
IFNG 4.63E-06 16.474 16.47 
PTGS2 1.31E-05 11.905 11.91 
IL1RN 6.36E-05 11.314 11.31 
HLA-DRB4 6.08E-06 10.976 10.98 
CMPK2 3.34E-06 10.880 10.88 
RTP4 2.20E-05 9.686 9.69 
HERC5 2.93E-06 9.056 9.06 
OAS2 1.35E-05 7.911 7.91 
LRRC50 4.48E-05 6.987 6.99 
HES4 1.01E-05 6.833 6.83 
OASL 1.54E-05 6.686 6.69 
IRF7 2.90E-05 6.073 6.07 
OSM 0.000119332 5.492 5.49 
PRIC285 3.67E-05 5.395 5.40 
DTX3L 0.000131167 5.285 5.29 
BATF 3.76E-05 5.039 5.04 
FAM46A 5.13E-05 4.319 4.32 
XAF1 8.02E-05 4.308 4.31 
SAMD9 0.000106941 4.252 4.25 
ISG20 5.49E-05 4.147 4.15 
APOL6 0.000149483 3.882 3.88 
SPRY2 8.10E-05 3.752 3.75 
IFIT5 5.43E-05 3.719 3.72 
IFI6 0.000212218 3.689 3.69 
AXUD1 6.99E-05 3.672 3.67 
HRASLS2 5.91E-06 3.552 3.55 
IFI16 0.000190927 3.292 3.29 
CSF3R 8.58E-05 3.150 3.15 
PI3 3.71E-05 3.110 3.11 
TAP1 7.92E-05 2.959 2.96 
CFB 0.000176291 2.920 2.92 
CYP2J2 0.000160029 2.908 2.91 
MGC4677 1.41E-05 2.821 2.82 
DCUN1D3 1.05E-05 2.706 2.71 
KIR2DS3 0.000109255 2.439 2.44 
TM4SF1 0.000209426 2.285 2.29 
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MYOM2 0.000108479 2.261 2.26 
GSTT1 8.36E-05 1.986 1.99 
TRAF3IP2 0.000175574 1.949 1.95 
BAG3 0.000190924 1.795 1.80 
C8ORF55 0.000126846 1.714 1.71 
FXYD6 1.23E-05 1.701 1.70 
CCR5 0.000133365 1.267 1.27 
ASAH1 6.44E-06 0.705 -1.42 
AVPI1 0.000119859 0.380 -2.63 
CTSB 2.57E-05 0.376 -2.66 
LYL1 0.000183242 0.333 -3.00 
ADAP2 3.60E-05 0.246 -4.06 
ZNF683 0.000139422 0.151 -6.64 
SLCO2B1 0.000112625 0.141 -7.11 
HLA-DRB1 4.60E-05 0.028 -35.58 
HLA-DRB5 2.33E-05 0.021 -48.69 
 
Table 7 
Comparison of gene expression between the most radiosensitive 
and most radioresitant donor. Gene expression of the donor with 
the highest frequency of DC formation (donor 5) was compared with 
the donor with the lowest frequency of DC formation (donor 7) post 
gamma radiation. The cut off is set on an absolute fold change of 4 
(p<0.05). All changes are compared versus all doses. The fold change 






Our results support earlier studies that low dose gamma radiation 
induces a dose-dependent increase in DNA damage and genomic 
aberrations (Awa et al., 1992, Bender et al., 1988, da Cruz et al., 
1994, Straume et al., 1991). Hence, these could be potentially used as 
indicators of dose of exposure.  
Radiation is known to damage the cells by inducing DSBs. Therefore, 
it is plausible that the levels of DSBs would correlate with the dose of 
exposure. We observed the levels of DSBs due to low dose gamma 
radiation exposure (0.1-1.0 Gy) with the use of an antibody to γH2AX, 
which is an early marker for DSB and signal for the initiation for DNA 
damage repair (Lavin et al., 1995). Consistent with previous reports 
(Rothkamm and Lobrich, 2003), we observed a dose-dependent 
response in γH2AX foci 2 hours post irradiation. We detected small 
inter-individual variation among the donors but this was not significant 
which is consistent with previous reported data (Garty et al., 2010, 
Wang et al., 2014). DSBs were reduced (average 0.28 γH2AX foci per 
cell) back to basal level (average 0.12 γH2AX foci per cell) twenty four 
hours post irradiation (Figure 8D). This indicates that most of the 
DSBs were either repaired or removed within 24 hours post irradiation. 
This is consistent with previous data that described the DNA repair 
mechanism induced by γH2AX (Keogh et al., 2006). Immunostaining 
of γH2AX as marker for the DSBs seems to be a viable option for dose 
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estimation. In case of mass causality, adjustments could be made to 
this technique by combining it with flow cytometry which would make it 
a rapid and sensitive method to make a reliable dose estimation even 
at low doses (Wang et al., 2014). This study showed a time dependent 
decrease of γH2AX foci and low inter-individual variation. Age, gender 
and smoking status were checked and had no significant effects on 
basal levels of induced γH2AX foci, therefore, it is assumed that inter-
individual variation is neglectable (Wang et al., 2014). This means 
samples have to be processed as soon as possible after irradiation 
and time of exposure should be known to make reliable dose 
estimation. Whether this is possible depends on the logistics and 
situation when samples have to be analysed. Overall, measurement of 
γH2AX levels is a realistically deployable technique in biodosimetry 
during events of exposure to gamma radiation – both in terms of 
carrying out the experiment and the reliability of the outcome. 
Although it would be an uphill task to do so before the onset of decay 
of γH2AX, owing to its rapid kinetics within the cell. 
Next, we analysed the levels of MN, an indicator of genomic integrity 
of a cell, with the use of cytokinesis blocked micronucleus assay 
(CBMN). It has been shown that MN formation in lymphocytes after 
exposure to low dose gamma radiation is dose-dependent and that 
CBMN assay can be used as a robust biodosimeter at low dose 
radiation exposure (Vral et al., 2011). We observed a dose-dependent 
increase of DNA damage after exposure to gamma radiation (Figure 
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9C-D). To reiterate, γH2AX foci exhibited a rapid decay within 24 
hours of gamma radiation exposure, in our study. However, 
intriguingly enough, as described above, MN was seen increasingly 
prevalent with higher doses of exposure on the same samples. In fact, 
MN was visualised as much as 72 hours post-exposure. Thus the 
disappearance of much of γH2AX foci after 24 hours translates into 
the cells having sensed the DSBs and having resolved it – either 
repaired it or misrepaired it – in an effort to continue proliferating. In 
addition, those persistent γH2AX foci would translate into the fact that 
a minute fraction of cells are still arrested and are in the process of 
repairing the damage, and hence, will not be picked up by the CBMN 
assay that only detects cells that are dividing. 
Significant inter-individual variation was detected among the donors 
which could be due to the fact that levels of MN are not specifically 
induced by radiation exposure. The basal levels of MN depends on 
several factors like age, gender, diet and lifestyle and therefore vary 
among donors (Fenech and Bonassi, 2011). We observed an increase 
in variation among the donors, especially at higher doses of exposure. 
This indicates that the physiological state of the cells has influence on 
the response to DNA damage induced. Overall, when cells are 
exposed to a DNA damaging agent like radiation, various possibilities 
determine whether the cells can be visualised with CBMN or not. On 
one hand, those cells that escape the radiation hit and those that 
manage to heal the DNA damage without traces of DNA would not 
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possess any MN. On the other hand, those cells, after being hit by 
radiation, that either managed to resolve the damage with extra stray 
DNA fragment(s) or failed to repair the damage or ended up with 
lagging chromosomes during cell division, tend to manifest such 
aberrations in the form of MN (Fenech, 2007, Goodhead, 1989). The 
fact that DNA damage is not induced specifically due to radiation 
exposure will complicate dose estimation at low doses. Another 
drawback of this method is that only dividing cells will be analysed, as 
only cells which underwent one cell cycle are taken into account. If the 
method is expanded to CBMN cytome assay, levels of apoptosis and 
necrosis and ratios of mono-, bi- and multi-nucleated cells can be 
analysed as well (Fenech, 2007). In that case, this will give a more 
complete picture of the fate of the cells. Also the fact that all cells have 
to undergo one cell cycle and thus cells have to be cultured for at least 
72 hours before the results can be obtained.  
Thereafter, in our further quest for biomarkers of low dose gamma 
radiation exposure, we analysed the levels of chromosomal aberration 
in the same set of samples. We detected a dose-dependent increase 
in levels of dicentric which are specifically induced by radiation 
exposure as previously reported (Tucker et al., 1993). We also 
identified a dose-dependent increase in the frequency of chromosomal 
aberration in general (Figure11A). The complexity of the chromosome 
aberrations becomes more apparent at higher doses of ionising 
radiation which was reported before (Finnon et al., 1995). This 
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indicates that at low doses the chromosome aberrations seen are less 
complex such as loss of telomere signals, single stranded breaks or 
ring chromosomes. In our study, we observed the same trend – the 
higher the dose, the more complex the aberrations were (Figure 10A-
K). This was expected, especially after CBMN assay, a reliable 
measure of genome integrity, showed increasing MN occurrence with 
increasing dose of exposure to gamma radiation, in our study. We 
looked into more detail - the complexity of the aberrations with the use 
of mFISH. Some studies used mFISH to show that even low doses of 
radiation are capable of inducing complex aberrations that require at 
least four breaks for their formations (Loucas et al., 2004). We did not 
observe complex aberration in doses lower than 0.5 Gy. We observed 
inter-individual variation in both – dicentric formations as well as in 
chromosomal aberrations. Since dicentrics are commonly induced by 
radiation exposure, we compared if the donors with high levels of 
dicentric formation are also the ones that had high levels of MN 
formation or γH2AX foci but there was no significant correlation 
between the different experiments, although the same set of samples 
was used. This might be due to the fact that both γH2AX and MN are 
not specifically induced by radiation exposure alone and therefore the 
genetic background and physiological state of the cells might interfere 
with the results. There is no data available on studies following such a 
multi-parametric approach, and hence comparison with other studies 
becomes difficult. The fact that inter-individual variation was observed 
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in all cytogenetic techniques indicates that the effects due to low dose 
radiation exposure are not uniform and depend upon the physiological 
state and/or genetic background of the cells. The identification of 
biomarkers which could provide information about radiation 
susceptibility could be useful for patients who undergo radiotherapy as 
cancer treatment. If we could define radiation susceptibility before a 
patient undergoes radiotherapy, the dose; dose rate and or 
fractionations of radiotherapy could be adjusted to an individual 
capability. These results emphasise again that inter-individual 
radiation susceptibility is an important fact to keep in consideration in 
biodosimetry. 
In a scenario where large populations are exposed to radiation, 
management of the crisis would be cumbersome as there is no way to 
determine the dose to which the population has been exposed and 
levels of radiation that require medical intervention. The conventional 
biodosimetry techniques discussed before are time consuming and 
labour intensive, a recent estimation done in collaboration of 15 
countries of the European Union indicated a total capacity for 
dosimetry triage of 1500 cases per week (Wojcik et al., 2010). Even 
though these assays are well established biomarkers for radiation 
exposure, in case of mass casualties, the use of these assays may 
prove even to be harmful to the individuals exposed to high doses that 
would require impromptu medical attention. Hence, there is a need for 
efficient and effective biomarkers and approaches to dosimetry in 
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order to assign the individuals with significant exposure as soon as 
possible to appropriate medical care (Kabacik et al., 2011).  
Gene expression profiling seems to be promising in this case. By 
identifying specific genes as markers, a screen for that marker would 
enable a faster identification of individuals that require immediate 
medical attention. Technological advances in genomics have helped 
in determining many radiation-sensitive biomarkers. Many studies 
have shown that microarray or molecular approaches of using gene 
expression profiles can be used as putative biodosimeters.  Most such 
approaches are using peripheral blood as it is easily accessible and 
radiation-sensitive. Gene expression was measured in whole blood 
(Blakely et al., 2001, Grace et al., 2003, Paul and Amundson, 2008), 
isolated lymphocytes (Amundson et al., 2000, Miller et al., 2002, 
Dressman et al., 2007, Meadows et al., 2008, Turtoi et al., 2008) or T-
cells (Mori et al., 2005, Mori and Desaintes, 2004). The complex 
kinetics, multiple parameters and the inter-individual variance make it 
difficult to compare and interpret these studies. 
We generated gene expression profiles in the same samples as the 
ones used for cytogenetic assays. We determined gene expressions 
after radiation exposure at different doses (0.1 - 1.0 Gy) and 
compared that with the control cells from the same donor. This paired-
analysis helps to account for the individual difference in basal gene 
expression levels. We analysed the samples at 2 and 24 hours post-
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irradiation and observed that the biggest variation occurred due to the 
time after exposure. This indicates that the variation in gene 
expression mainly depends on the time between the exposure and 
analysis instead of the dose of exposure. Therefore, gene expression 
profiling would be a probable biodosimeter if the duration of time 
between exposure and analysis is known. We analysed gene 
expression combined for 2 and 24 hours and identified the genes 
differentially expressed in all 4 doses compared with own control 
values and found a list of potential biomarkers. Most of these markers 
are involved with DNA repair pathways. This is in accordance with 
previous studies which analysed gene expression profiles (Paul and 
Amundson, 2008). It is remarkable to note that out of the 4 genes that 
were significantly deregulated across all doses and time points, 3 of 
them – GADD45α, CDKN1A (p21) and ISG20L1 are all executors of 
cell arrest following robust DNA damage-mediated checkpoint 
activation and were all upregulated in our study, following radiation 
exposure (Table 6C). GADD45α is known for its ability to stimulate 
DNA excision repair, bind to PCNA (a component of cyclin-dependent 
kinases) and halt cell cycle progression specifically following ionising 
radiation exposure (Papathanasiou et al., 1991, Smith et al., 1994). 
CDKN1A (p21) binds to CDK complexes, thereby rendering them 
ineffective and halting cell progression (Harper et al., 1993). Together 
with p53, p21 forms a robust and fool-proof executor of cell arrest (el-
Deiry et al., 1993). Interestingly, GADD45α and p21 have been shown 
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to physically interact with each other (Carrier et al., 1994). ISG20L1 
was identified as a radiation-specific exonuclease that functions to 
enhance apoptosis (Lee et al., 2005). 
Thus far, our study has shown that the cytogenetic end points 
analysed – MN, dicentrics, and other described chromosomal 
aberrations – may not be feasible to be deployed as biomarkers of 
exposure to gamma radiation in real time scenarios and as stand-
alone biomarkers of exposure, but could, nonetheless, be highly 
useful and reliable as biomarkers of sensitivity and would be 
advantageous when combined with other parameters. In addition, we 
were also interested in analysing the difference in gene expression 
between that of the most radiosensitive donor (the donor with the 
highest percentage of dicentric formation after exposure to 1.0 Gy of 
radiation) and that of the least radiosensitive donor (the donor with the 
lowest percentage of dicentric formation at 1.0 Gy radiation). We 
identified a list of genes that are potential biomarkers for radiation 
sensitivity. The gene signature obtained, once confirmed in a bigger 
population study, could be used as biomarkers of sensitivity to gamma 






Biomarker identification following 
exposure to heavy ions 
4.1 Background 
Thus far in the study, we focussed on understanding the effects and 
unravelling potential markers of gamma irradiation on human 
lymphocytes. We expanded our study to analyse the effects of low 
dose heavy ion radiation on human lymphocytes from healthy 
individuals (0.1 – 1 Gy) in order to identify biomarkers of exposure to 
heavy ions. Two different heavy ions, carbon and iron were used in 
the study (Sections 4.2.1 & 4.3.1). 
The term heavy ion is used for particles heavier than helium ions. 
Particle radiation has a small mass which respond differently while 
traveling through matter compared to photons. Therefore, their 
response and interactions in the body is different from that of gamma 
radiation. Protons and heavy ions need to be accelerated with 
cyclotrons or synchrotrons and deliver their energy when they reach 
their penetration depth (Fokas, Kraft, An, & Engenhart-Cabillic, 2009). 
The loss of radiant energy while traveling through matter can be 
shown in a Bragg’s curve. Figure 19 shows the difference in energy 
loss between gamma radiation, protons and carbon ions. Photons lose 
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energy while traveling through any matter while protons and heavy 
ions only deliver their energy when they reach their penetration depth. 
These properties render heavy ions its specific qualities, the 




Bragg’s curve that shows the energy distribution of photons, 
proton and carbon ions while traveling through water. Gamma 
radiation is composed of photons which respond in a different way 





4.2 Carbon ions  
4.2.1 Background 
Heavy ions are characterised by a high energy which is deposited at 
the end of their track. The energy of heavy ion radiation can be 
localised to a specific area and induce more precise cellular 
inactivation (Hall, 2006). As such, biological effectiveness of heavy ion 
exposure is higher compared to gamma radiation (Hall, 2006). This 
property makes heavy ion radiotherapy potentially superior to 
conventional radiotherapy (Gerlach et al., 2002).  
The advantage of a higher relative biological effectiveness (RBE) 
makes carbon ion exposure suitable for deep-seeded tumours and/or 
tumours in surroundings with sensitive tissues (Gerlach et al., 2002). 
The use of heavy ions like carbon ions in radiotherapy may result in a 
more effective treatment compared to the conventional radiotherapy 
but the surrounding tissue may get exposed to low doses of carbon 
ions (Hall, 2006). Therefore, it is important to analyse effects of 
exposure to low doses of carbon ions. 
Medical treatment of cancer can be divided into surgery, 
chemotherapy and radiotherapy but often a combination of these 
treatments is used. The ultimate aim for cancer therapy is to remove 
the fast dividing cancer cells without harming normal, healthy cells in 
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the vicinity of the tumour and the neighbouring tissues. Radiotherapy 
is the mainstay of cancer treatment and is used in approximately 50% 
of the current cancer cases (Baskar et al., 2012). Cancer cells are 
more susceptible to radiation due to their fast dividing properties and 
compromised DNA damage response. In the Chapter 3, the effects of 
gamma radiation – the conventionally used source of radiotherapy – 
which consist of photons which possess energy without any mass, 
were described. Within the last two decades, the use of particle 
therapy has gained interest (Jakel et al., 2003). Particle radiation 
consists of proton radiation and heavy ion radiation. Among several 
types of ion species, carbon ions were chosen for cancer therapy 
because they were judged to have the most optimal properties, in 
terms of superior physical and biological characteristics (Sekine et al., 
2008). For carbon radiation, the dose can be more precisely focussed 
on a localised area in a tissue, and therefore the biological effect of 
this type of radiation is superior to that of gamma radiation, and 
hence, is a more promising source of radiation for cancer treatment 
(Loeffler and Durante, 2013). However, the side effects cannot be 
ignored, as studies have shown that heavy ions have higher capacity 
of cell killing than gamma and X-rays this might also affect healthy 
surrounding tissue  (Sekine et al., 2008). 
The world’s first clinical centre offering carbon ion based radiotherapy 
was opened at the National Institute of Radiological Sciences (NIRS), 
Japan in 1994 (Okada et al., 2010). Later the BEVALAC accelerator in 
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Berkeley, CA, USA and GSI SIS accelerator in Darmstadt, Germany  
started carbon ion radiotherapy (Schulz-Ertner et al., 2004). Japan is 
still the pioneer in carbon ion based radiotherapy with currently 10 
operational facilities in this field. Most studies thus far have shown 
positive effects of carbon ion radiation in in vivo as well as in in vitro 
(Amornwichet et al., 2014, Demizu et al., 2014, Sulaiman et al., 2014). 
However, due to the high cost of the technical realisation of the 
facilities there is only a small number of controlled randomized clinical 
trials that have been conducted. Therefore, the cost-to-benefit ratio 
remains a controversial point. Thus it is imperative that more 
extensive research is conducted, which may lead to a deeper 
understanding of the toxic effects of the use of carbon ion exposure. 
The aim of this part of the study is to determine if there is a difference 
in biomarkers between carbon ion exposure and gamma radiation at 
the chromosomal and gene expression level; to add to the knowledge 
of existing findings on carbon ion exposure on human cells; and to 
attempt a cataloguing of biomarkers specific to exposure to carbon ion 






4.2.2.1 Chromosomal aberrations and dicentric formation 
following carbon ion exposure 
Analyses of chromosomal aberrations are a routine when it comes to 
studies on the biological effects of any type of radiation. To analyse 
chromosomal aberrations and the formation of dicentrics, we 
performed PNA in situ hybridisation with probes specific to the 
centromeric and telomeric region as explained in Chapter 3. Human 
peripheral blood lymphocytes of three healthy donors were isolated 
and exposed to different doses of carbon ions (0, 0.1, 0.25, 0.5 and 1 
Gy).  The samples were processed – lymphocytes isolated from whole 
blood and kept in culture – within 1 hour of exposure. Metaphases 
thus obtained were analysed for incidence of breaks, fusions and 






















        0 22 0 0 0 (0/cell) 0 (0%) 0 (0/cell) 
0.1 71 5 2 7 (0.10/cell) 6 (8%) 0 (0/cell) 
0.25 54 7 3 8 (0.15/cell) 8 (15%) 3 (0.05/cell) 
0.5 32 9 12 17 (0.53/cell) 10 (31%) 10 (0.31/cell) 
1 47 25 16 29(0.34/cell) 15 (32%) 15 (0.32/cell) 
                








0 54 0 0 0 (0/cell) 0 (0%) 0 (0/cell) 
0.1 81 5 0 5 (0.06/cell) 5 (6%) 0 (0/cell) 
0.25 81 13 10 23 (0.28/cell) 11 (14%) 9 (0.11/cell) 
0.5 60 13 16 29 (0.48/cell) 17 (28%) 15 (0.25/cell) 
1 59 41 23 64 (1.08/cell) 21 (36%) 16 (0.27/cell) 
                








0 88 1 0 1 (0.01/cell) 1 (1%) 0 (0/cell) 
0.1 66 0 0 0 (0/cell) 0 (0%) 0 (0/cell) 
0.25 65 8 5 13 (0.20/cell) 6 (9%) 4 (0.06/cell) 
0.5 39 15 12 27 (0.69/cell) 12 (31%) 11 (0.28/cell) 
1 56 24 24 48 (0.86/cell) 17 (30%) 20 (0.36/cell) 
                
        Table 8 
Analysis of chromosomal aberrations in metaphases from human 
peripheral blood lymphocytes after exposure to various doses of 
carbon ions. Breaks include double minutes; acentric fragments; 
centric fragments and undetected telomeres. Fusions include 
dicentrics, tricentrics, sister chromatid fusions and ring formations. We 
checked for breaks, fusions, dicentrics and a total of all observed 
aberrations. The percentage of aberrant cells was calculated 
according to the number of metaphases analysed. Dose-dependent 
increase of aberrations and dicentric formations was observed with 
increasing carbon ion exposure. Two way ANOVA was performed to 
asses statistical analysis. 
 
We classified aberrations as breaks (consisting of double minutes, 
acentric fragments, centric fragments, chromatid breaks and 
undetected telomeres) and fusions (consisting of sister chromatid 
fusions, dicentrics, tricentric, rings, and complex fusions). Since 
dicentrics are considered specific to radiation exposure, we recorded 
the occurrence of dicentric formation as a stand-alone parameter. 
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There was a dose-dependent increase with respect to total 
aberrations per cell (0.05 aberrations/cell after 0.1 Gy to 0.76 
aberration/cell after 1 Gy); percentage of aberrant cells (4.6% aberrant 
cells after 0.1 Gy to 32.7% aberrant cells after 1 Gy); and number of 
dicentric chromosomes per cell (0 dicentrics/cell after 0.1 Gy to 0.32 











Chromosome aberrations observed in human lymphocytes after exposure to various doses of carbon ions A. Overview of 
total chromosomal aberrations per analysed cell. B. Frequency of dicentric formations per analysed cell. C. Percentage of aberrant 
cells following carbon ion exposure, represented as the number of cells carrying aberrations per 100 analysed cells. We observed a 
dose-dependent response in chromosomal aberrations, dicentric formations and percentage of aberrant cells after exposure to 
carbon ions. Statistical significance between the doses was assessed using two way ANOVA, using Graphpad Prism. The difference 
was considered statistically significant when *P<0.05; **P<0.01 and ***P<0.001. 
A B C 
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4.2.2.2 mFISH to analyse type of aberrations following 
carbon ion exposure  
mFISH was used to get more insights of the chromosomal aberrations 
observed and to identify the ratio of reciprocal, non-reciprocal and 
complex chromosomal translocations. We analysed three peripheral 
lymphocyte samples (the same samples used in telomere PNA-FISH) 
exposed to 1 Gy carbon ions and compared it with unirradiated cells of 
the respective donors. On an average, each cell displayed 1.08 
aberrations of all kinds – non-reciprocal, reciprocal and complex 
translocations after exposure to 1 Gy carbon ions (Table 9 and 
Figure 22). Often, more than one type of aberration was concurrently 
observed in the same cell. We found an average of 68.8% of the 
analysed metaphases with non-reciprocal aberrations, 10.9% with 
reciprocal aberrations, 4% with complex aberrations and 24.3% with 
other aberrations – breaks, deletions and duplications. An example of 
a complex exchange is shown in Figure 21. To analyse if certain 
chromosomes were more susceptible to the effects of exposure to 
carbon ions, we monitored the chromosomes which were involved in 
any of the observed aberrations (Figure 23). We found that 
chromosome 1 was often involved in chromosomal aberrations. 
Observations such as these could be potentially useful when 




especially on the same samples. The following section outlines the 
findings from our study. 
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 0 19 0 0 0 0 0 0 0 
1 57 20 75.4 7 5.3 35.1 1.23 35.1 
D
2
 0 69 0 0 0 0 0 0 0 
1 60 16 46.7 11.7 1.7 11.7 0.72 26.7 
D
3
 0 61 0 0 0 0 0 0 0 
1 57 23 84.2 14 5.3 26.3 1.3 40.4 
 
Table 9 
Ratio of chromosomal aberrations in metaphases from human lymphocytes after exposure to 1 Gy carbon ions. Cells 
were analysed for the number of non-reciprocal, reciprocal, complex translocations and other aberrations (deletions, duplication 
and breaks). The percentage was calculated according to the number of cells analysed. Average aberrations per cell are the 
sum of all detected aberrations divided by the number of analysed cells. The percentage of aberrant cells is the calculated with 
the number of aberrant cells divided by the number of analysed cells. All aberrations were observed in samples of human 






























Chromosome rearrangements in human lymphocytes exposed to 
1 Gy carbon ions by mFISH. A cell from an irradiated sample, 
showing complex chromosome translocation involving three 
chromosomes: 1, 5 and 10. Metaphases are hybridized for 72 hours 
with mFISH probes with 5 different labels which can be detected with 
a fluorescence microscope with the filters: FITC, Cy3.5, Texas Red, 








Ratio of chromosome rearrangements in human lymphocytes 
after exposure to 1 Gy carbon ions. Non-reciprocal, reciprocal, 
complex exchanges and other aberrations observed using mFISH 
analysis in three donors. Complex exchanges are the result of 
reconstitution of more than 3 breaks in at least 2 chromosomes; and 




Distribution of aberrations in all chromosomes after exposure to 
1 Gy carbon ions. Data represents the frequency of occurrence of 
translocations and other aberrations in each chromosome, as 
analysed using mFISH. Values represent data pooled from analysis of 
all three donors. 
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4.2.2.3 Analysis of gene expression profiles following 
exposure to carbon ions 
In an attempt to catalogue signature markers of carbon ion exposure 
and to understand the molecular changes, genome-wide gene 
expression microarray was performed on the same three samples of 
lymphocytes in addition to the cytogenetic analysis described earlier. 
Two time points, 2 and 24 hours, were selected following exposure to 
0.1, 0.25, 0.5 and 1 Gy of carbon ions. For each time-point and for 
each dose, individual gene lists, containing significantly differential 
expressed genes following paired t-tests between profiles of cells 
irradiated and those of unirradiated control cells, were created (Figure 
24). Analysis using Venn diagrams (by pooling all the individual gene 
lists) revealed a total of 2437 genes differentially regulated in at least 
one of the doses – 0.1, 0.25, 0.5 or 1 Gy at two hours (Figure 25A). 
At twenty four hours post-irradiation, we found 2236 such genes 
(Figure 25B). Although there were no overlapping genes between all 
lists at both the time points, and between all four lists – 0.1 Gy vs 
Control, 0.25 Gy vs Control, 0.5 Gy vs Control and 1 Gy vs Control – 
at 2 hours, an average of 10 genes among any 3 lists at 2 hours and a 
total of 5 genes among all 4 lists at 24 hours, were differentially 
expressed (Figure 25 A&B). After 24 hours, we found 5 genes 





Principal component analysis of various data points following carbon ion exposure. Principal component analysis of 
various data points.showing no obvious clustering by dose or donors, but striking pattern by time. Each sample was coloured 




Venn Diagram of numbers of significantly differentially expressed genes following carbon ion exposure A. 2 hours B. 
And 24 hours post exposure to different doses of carbon ions. Values within parentheses stand for numbers of differentially 
expressed genes (as analysed using Partek Genomic Suite) for the respective dose as compared to unirradiated controls of the 
same time-point post irradiation. Values within the area enclosed by different colours indicate the numbers of differentially 
expressed genes that overlapped with the circles of intersection.  
A B 















0.1 Gy 0.25 Gy 0.5 Gy 1.0 Gy 
C3ORF42 0.893 -1.120 0.906 -1.104 0.877 -1.140 0.845 -1.184 
DPEP1 0.920 -1.086 0.897 -1.114 0.881 -1.135 0.864 -1.158 
DUOXA2 0.880 -1.136 0.835 -1.198 0.880 -1.136 0.804 -1.244 
FLJ44635 0.909 -1.101 0.851 -1.175 0.887 -1.127 0.843 -1.186 
PCDHB1 0.920 -1.086 0.908 -1.101 0.946 -1.057 0.913 -1.095 
 
Table 10 
Most significant genes after exposure to different doses of carbon ions. Genes differentially expressed after carbon ions at 
2 and 24 hours post-irradiation. All values are compared with their respective unirradiated controls, obtained by paired t-test 
analysis between each dose and control for every donor (P<0.05). 
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4.3 Iron ion radiation 
 Another type of heavy ion that warrants further investigation is iron 
ion exposure. Besides being a potential and more efficient method for 
radiotherapy for medical benefits, the effects of heavy ion radiation 
has been analysed as astronauts are exposed to heavy ion radiation 
during space exploration. The hazards of space exploration are 
coming from solar particle events and galactic cosmic rays. Not much 
data is available in this regard and most of the safety regulations for 
space explorations have been based on extrapolated data from 
studies on heavy ion radiation. Galactic cosmic rays consist out of 2% 
electrons, 98% baryons and 1% of heavy ions, of which iron ions 
contribute significantly to the total radiation dose (Hellweg and 
Baumstark-Khan, 2007). Hence, we extended our investigation of the 
effects of heavy ion radiation in the form of iron ion exposure too. In 
addition to understand the biological and toxic effects of iron ion 
exposure, by employing the genome-wide gene expression analysis of 
human lymphocytes, we also attempted to identify a panel of gene 
signatures that could specifically detect exposure to iron ions; so as to 
stratify cases for further treatment as may be necessary, as in the 





4.3.1.1 Chromosomal aberrations and dicentric formation 
following iron ion exposure 
In order to compare our study to the ones catalogued in literature, we 
started our investigation of iron ions with the analysis of chromosomal 
aberrations after exposure of the lymphocytes to doses – 0.1, 0.25, 
0.5 and 1 Gy. Samples were processed within 1 hour of exposure. 
Metaphases were analysed for the presence of breaks, fusions and 
dicentric formations. There was a dose-dependent increase with 
respect to total aberrations per cell (0.19 aberrations/cell after 0.1 Gy 
to 0.96 aberration/cell after 1 Gy); percentage of aberrant cells (14% 
aberrant cells after 0.1 Gy to 32% aberrant cells after 1 Gy); and 
number of dicentric chromosomes per cell (0.01 dicentrics/cell after 
0.1 Gy to 0.27 dicentrics/cell after 1 Gy) (Table 11). Interestingly, 
there was a punctuated increase in the above-mentioned aberrations 
with exposure to 1 Gy iron ions as compared to the lower doses 
















  (Gy) Analysed 
 








0 100 10 0 10 (0.10/cell) 10 (10%) 0 (0/cell) 
0.1 100 12 0 12 (0.12/cell) 10 (10%) 0 (0/cell) 
0.25 100 11 2 13 (0.13/cell) 8 (8%) 1 (0.01/cell) 
0.5 100 28 17 45 (0.45/cell) 22 (22%) 15 (0.15/cell) 
1 100 77 29 106 (1.06/cell) 34 (34%) 28 (0.28/cell) 
        








0 100 14 0 14 (0.14/cell) 12 (12%) 0 (0/cell) 
0.1 100 23 3 26 (0.26/cell) 16 (16%) 3 (0.03/cell) 
0.25 100 9 5 14 (0.14/cell) 7 (7%) 5 (0.05/cell) 
0.5 100 23 7 30 (0.30/cell) 19 (19%) 6 (0.06/cell) 
1 100 66 29 95 (0.95/cell) 34(34%) 29 (0.29/cell) 
        








0 98 12 2 12 (0.12/cell) 9 (9.2%) 2 (0.02/cell) 
0.1 100 19 0 18 (0.18/cell) 16 (16%) 0 (0/cell) 
0.25 100 11 3 14 (0.14/cell) 9 (9%) 3 (0.03/cell) 
0.5 100 31 21 52 (0.52/cell) 21 (21%) 20 (0.20/cell) 
1 100 57 29 86 (0.86/cell) 29(29%) 25 (0.25/cell) 
                
        Table 11 
Analysis of chromosomal aberrations in metaphases from human 
peripheral blood lymphocytes after exposure to various doses of 
iron ions. Hundred cells were analysed for each condition. Breaks 
include double minutes; acentric fragments; centric fragments and 
undetected telomeres. Fusions include dicentrics, tricentrics, sister 
chromatid fusions and ring formations. We checked for breaks, 
fusions, dicentrics and a total of all observed aberrations. The 
percentage of aberrant cells was calculated according to the number 
of metaphases analysed. Dose-dependent increase of aberrations and 
dicentric formations was observedwith increasing iron ion exposure. 









Chromosome aberrations observed in human lymphocytes after exposure to various doses of iron ions A. Overview of total 
chromosomal aberrations per analysed cell. B. Frequency of dicentric formations per analysed cell. C. Percentage of aberrant cells 
following iron ion exposure, represented as the number of cells carrying aberrations per 100 analysed cells. We observed a dose-
dependent response in chromosomal aberrations, dicentric formations and percentage of aberrant cells after exposure to iron ions. 
Statistical significance between the doses was assessed using two way ANOVA, using Graphpad Prism. The difference was 
considered statistically significant when *P<0.05; **P<0.01 and ***P<0.001. 
A B C 
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4.3.3.2 mFISH to analyse type of aberrations following iron 
ions exposure 
In order to detect subtle chromosomal aberrations that are crucial in 
determining cell fate, but are undetectable by telomere and 
centromere FISH, mFISH analysis was done following exposure to 1 
Gy of iron ions and compared it with unirradiated cells of respected 
donors. On an average each cell displayed 0.42 aberrations of all 
kinds - non-reciprocal, reciprocal and complex translocations, after 
exposure to 1 Gy iron ions (Table 12 and Figure 27). Often, more 
than one type of aberration was concurrently observed in the same 
cell. We identified non-reciprocal translocations in 28.2% of the 
analysed cells, reciprocal translocations in 3.6% of the cells, complex 
exchanges in 0.7% of the cells and other aberrations – breaks, 
deletions and duplications – in 9.8% of the cells (Figure 28). To 
analyse if certain chromosomes were more susceptible to the effects 
of exposure to iron ions, we monitored which chromosomes were 
involved in any of the aberrations analysed, but found no particular 
bias in the distribution of chromosomal aberrations (Figure 29).  
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 0 52 0 0 0 0 0 0 0 
1 45 6 13.3 4.4 0 6.7 0.24 13.3 
D
2
 0 26 0 0 0 0 0 0 0 
1 46 8 28.3 2.2 2.2 13 0.46 17.4 
D
3
 0 100 0 0 0 0 0 0 0 
1 93 15 43 4.3 0 9.7 0.57 16.1 
 
Table 12 
Ratio of chromosomal aberrations in metaphases from human lymphocytes after exposure to 1 Gy iron ions. Cells were 
analysed for the number of non-reciprocal, reciprocal, complex translocations and other aberrations (deletions, duplication and 
breaks). The percentage was calculated according to the number of cells analysed. Average aberrations per cell are the sum of 
all detected aberrations divided by the number of analysed cells. The percentage of aberrant cells is the calculated with the 
number of aberrant cells divided by the number of analysed cells. All aberrations were observed in samples of human 













Chromosomal rearrangements in in human lymphocytes exposed 
to 1 Gy iron ions by mFISH. A cell from an irradiated sample, 
showing complex chromosome translocation involving five 
chromosomes: 1, 2, 4, 9 and 10. Metaphases are hybridized for 72 
hours with mFISH probes with 5 different labels which can be detected 
with a fluorescence microscope with the filters: FITC, Cy3.5, Texas 
Red,Cy5 and Aqua. Chromosomes involved in this aberration are 







Ratio of chromosome aberrations in human lymphocytes after 
exposure to 1 Gy iron ions. Non-reciprocal, reciprocal, complex 
translocations and other aberrations observed using mFISH analysis 
in three donors. Complex exchanges are the result of reconstitution of 
more than 3 breaks in at least 2 chromosomes; and the category 
‘Others’ includes breaks, deletions and duplications.  
 
Figure 29 
Distribution of aberrations in all chromosomes after exposure to 
1 Gy iron ions. Data represents the frequency of occurrence of 
translocations and other aberrations in each chromosome, as 
analysed using mFISH. Values represent data pooled from analysis of 
all three donors. 
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4.3.3.3 Analysis of gene expression profiles following 
exposure to iron ions 
In order to get deeper insight into the molecular repercussions of iron 
ion exposure to human cells and in an attempt to identify specific gene 
signature that is capable of detecting signs of exposure to iron ions, in 
an unknown sample, we performed genome-wide gene expression 
microarray using HumanRef-Expression Bead Chips (Illumina) 
following exposure to 0.1, 0.25, 0.5 and 1 Gy of iron ions (Figure 30). 
Specific gene lists were arrived at, using paired t-test analyses for 
each dose versus unirradiated control and at each time-point – 2 and 
24 hours post-irradiation. When the gene lists were pooled as one, we 
identified 3378 differentially expressed genes after two hours (Figure 
31A) of which 8 overlap in the entire gene lists (Table 13A). Similarly, 
we identified 4437 genes differentially expressed after 24 hours after 
irradiation (Figure 31B), of which 7 genes appeared commonly in the 





Principal component analysis of various data points following iron ion exposure. Principal component analysis 
of various data points showing no obvious clustering by dose or donors, but a striking pattern by time. Each sample 
was coloured based on: A. number of donors (D1-D3) B. doses (0.1 -1.0 Gy) and C. post-irradiation time point (2 







Venn Diagram of numbers of significantly differentially expressed genes following iron ion exposure A. 2 hours and B. 
24 hours post exposure to different doses of iron ions. Values within parentheses stand for numbers of differentially expressed 
genes (as analysed using Partek Genomic Suite) for the respective dose as compared to unirradiated controls of the same time-
point post irradiation. Values within the area enclosed by different colours indicate the numbers of differentially expressed genes 
that overlapped with the circles of intersection. 
A 
B 




Ratio Fold Change Ratio Fold change Ratio Fold Change Ratio Fold Change 
0.1 Gy 0.25 Gy 0.5 Gy 1.0 Gy 
APOBEC3H 1.590 1.590 2.428 2.428 3.222 3.222 5.310 5.310 
CTSW 0.839 -1.191 0.892 -1.121 0.761 -1.314 0.660 -1.515 
GPER 0.820 -1.220 0.842 -1.188 0.724 -1.381 0.555 -1.801 
ISG20L1 1.729 1.729 2.836 2.836 3.682 3.682 5.501 5.501 
NR2E3 0.928 -1.077 0.915 -1.093 0.910 -1.099 0.932 -1.073 
RNF165 0.818 -1.223 0.808 -1.237 0.782 -1.279 0.641 -1.560 
TNFSF4 1.376 1.376 1.644 1.644 1.972 1.972 3.550 3.550 
 
Gene 
Ratio Fold Change Ratio Fold Change Ratio Fold Change Ratio Fold Change 
0.1 Gy 0.25 Gy 0.5 Gy 1.0 Gy 
C12ORF36 1.213 1.213 1.172 1.172 1.250 1.250 1.203 1.203 
C17ORF82 1.148 1.148 1.152 1.152 1.170 1.170 1.151 1.151 
C6ORF27 1.118 1.118 1.142 1.142 1.256 1.256 1.273 1.273 
CTSF 1.299 1.299 1.324 1.324 1.325 1.325 1.406 1.406 
P2RX6P 1.219 1.219 1.174 1.174 1.239 1.239 1.229 1.229 
SLAMF1 1.241 1.241 1.787 1.787 1.757 1.757 2.375 2.375 
SYT3 1.206 1.206 1.266 1.266 1.263 1.263 1.226 1.226 





Most significant genes after exposure to different doses of iron ions. A. Gene expression profiles 2 hours post 
exposure to iron ions. All values are compared with their respective unirradiated controls, obtained by paired t-test analyses 




Heavy ion radiation is a very newly characterised type of radiation. While its 
biological effects are not very well known yet, their superior potency over 
most ionising radiations make them compelling sources in a burgeoning 
variety of applications using heavy ion radiation like carbon ions in 
radiotherapy (Hall, 2006). In addition, another type of heavy ion radiation, 
produced by iron ions is prevalent in space and hence it becomes highly 
necessary for us to know of its imminent toxic effects upon exposure during 
manned space explorations particularly (Hellweg and Baumstark-Khan, 
2007). It follows that there is a fervent and urgent need to compound the 
currently available handful of studies on their effects and mechanisms in 
human cells. Here we present a comparison of existing studies and our 
current study on heavy ion radiation, namely carbon and iron ion exposure; 
present caveats in the interpretation of results from commonly used 
techniques to study their effects; and we attempt to add new knowledge using 
our genome-wide gene expression analyses of exposed human lymphocytes 
taken from healthy donors.  
Here, we show a dose-dependent increase in chromosomal aberration and 
dicentric formation after carbon ion exposure (Figure 20A-B). We observed 
0.76 average aberration per cell in the metaphase spreads analysed after 
exposure to 1 Gy carbon ions while that was 0.36 after exposure to gamma 
radiation. We observed levels of 31.7% dicentric formations in the analysed 
metaphase spreads while this was only 8.9% after 1 Gy gamma radiation. 
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Interestingly, the average levels of aberrant cells were 32.7% after exposure 
1 Gy carbon radiation while it was 20.6% after 1 Gy of gamma radiation 
exposure. We see a similar trend after exposure to iron ions (Figure 26A-B). 
We observed an average of 0.96 aberrations per cell and an average of 
32.3% of the cells contained dicentrics (Figure 32). These findings are 
consistent with assumption that heavy ion radiation harms the DNA in clusters 
due to the properties of densely radiation (Goodhead, 1994, Hada and 
Sutherland, 2006). Therefore more damage in individual cells can be detected 
while the percentage of aberrant cells only slightly increases. Our findings are 
bolstered by a study that concluded that dicentrics and ring formation can 
provide reliable dose estimates in the dose range from 0-4 Gy (Wang et al., 
2007). 
The cell cycle progression is effected due to exposure of high LET radiation 
(Nasonova and Ritter, 2004, Kawata et al., 2004). In the previous chapter we 
described the analysis of the effects of gamma radiation with the use of 
cytogenetic techniques, such as dicentrics assay. This includes the analysis 
of cells which underwent a single cell cycle. Levels of complex aberrations 
are correlated to misrepair which is induced after chromosome breaks and 
can therefore give more information about the initial DNA damage (Obe et al., 
2010). However, the levels of both – the dicentrics and complex exchanges 
might lead to an underestimation of the dose, as heavily damaged and 
arrested cells would not be accounted for, in this method, and hence, might 






Dicentric formation induced by different kinds of radiation. A percentage 
of the average dicentric formation observed in three donors.  
 
We observed the complexity of the aberrations in more detail with the use of 
mFISH. We found complex aberrations in 4% of the analysed metaphases 
after 1 Gy carbon ion irradiation and in 0.7% of all analysed metaphases after 
iron ion exposure, while we did not identify any complex aberration after 1 Gy 
gamma radiation. Interestingly, another study showed that an increase in 
complex aberrations is shown to be dose and LET dependent (Durante et al., 
2004, Loucas et al., 2004).  
The strikingly high proportion of complex exchanges observed in carbon ion 
exposure in particular, and in heavy ion radiation, in general, in our study 
could be attributed to their inherent ability to inflict concentrated, localised 
damage to chromosomes, leading to multiple breaks, which could lead to 
complex exchanges by illegitimate reconstitution of the fragments (Durante et 
al., 2004). Heavy ion radiation could fuel carcinogenesis in two documented 
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ways. Firstly, studies point out to a possibility of persistence of such 
exchanges over a few generations, and this might lead to gene dosage 
anomalies (Hande et al., 2005). Secondly, such radiation which has a 
tendency to inflict highly localised damage to chromosomes could lead to the 
phenomenon of chromothripsis – breakage of a chromosome segment into 
hundreds of shards – which while reconstituting, could very well lead to a 
potentially cancerous cell in a single event (Meyerson and Pellman, 2011, Liu 
et al., 2014).  
When we analysed the distribution of the aberrations, we found an increased 
amount of aberration in chromosome 1 after carbon ions exposure. 
Chromosome 1 is the largest chromosome and has therefore the highest 
chance to be hit by radiation exposure. Notably, this bias was not observed 
after gamma radiation or iron ions exposure (Figure 23&29). Also interesting 
to note is that no aberrations were detected in chromosome 20 after exposure 
to either carbon or iron ions as against some observed aberrations in our 
study on gamma radiation as previously mentioned. Although drawing 
comparisons with a study which revealed mouse chromosome 2 to be 
hypersensitive to mutations induced by ionising radiation exposure might 
seem far-fetched, it is nonetheless remarkable (Rithidech et al., 1995). More 
such studies could eventually pave way to a greater understanding behind 
chromosome bias in radiation exposure scenarios. 
The levels and identity of complex chromosomal aberrations induced by 
radiation species have major effects on the cell fate (Goodhead, 2010). As 
mentioned previously, cells have many ways to deal with moderate levels of 
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DNA damage. Therefore it would be useful to have molecular biomarkers 
which can be used as biodosimetry to make reliable risk estimation. The 
purpose of this chapter is to test the specificity of the gene signature identified 
upon exposure to gamma radiation by comparing and contrasting with that 
obtained upon exposure to heavy ion radiation; and also to identify possible 
specific gene signatures for application in testing one’s sensitivity to carbon 
ion exposure and in biodosimetry during exposure events relating to irons 
respectively. While the two time points of exposure assessed, 2 and 24 hours, 
pave way to a deeper understanding of the mechanistic effects of carbon ion 
exposure in human cells, the findings from such a study-design in iron ion 
exposure studies could directly translate into applicability in stratifying 
astronauts based on their exposure levels to iron ions during interplanetary 
missions (NCRP, 2000). 
Gene expression analysis resulted in five previously unreported genes that 
were significantly down regulated at all the different doses, 24 hours post-
irradiation. DUOXA2 is the maturation factor for DUOX2, which is a NADPH 
oxidase involved in ROS reduction (Hoste et al., 2012). FLJ44635 is a TPT1-
like gene which is a p53 target gene that promotes cell survival (Chen et al., 
2013). Another interesting gene that was significantly reduced in expression 
is PCDHB1, a gene that is regulated by meCP2 which is involved in mitotic 
spindle organization (Miyake et al., 2011). More extensive studies are crucial 
in this field to implicate more specific biomarkers and gain a better 




A similar approach in gene expression analysis upon iron ion exposure 
showed differential expression of 8 genes at all doses after 2 hours. Our 
analysis revealed that APOBEC3H, TNFSF4 and ISG20L1 were significantly 
upregulated in a dose-dependent matter. Intriguingly, all of those were 
reported as ionising radiation responsive genes (Paul and Amundson, 2011). 
Remarkably, they were also significantly upregulated in our gene expression 
data following exposure to gamma radiation. APOBEC3H is part of an 
intrinsic immune defence that has potent activity against a variety of 
retroelements while ISG20L1 is involved in orchestrating ionising-radiation 
induced apoptosis (Lee et al., 2005). Another gene that was in our list of 8 
genes was cathepsin W (CTSW) is a cysteine protease expressed in 
cytotoxic T cells (Linnevers et al., 1997, Brown et al., 1998, Wex et al., 2001). 
Twenty four hours post-exposure to iron ions, SLAMF1 was differential 
expressed in a dose-dependent matter. SLAMF1 is reported to be involved in 
T-cell activation (Detre et al., 2010). Overall, while a handful of these genes 
that emerged as significantly deregulated upon radiation exposure, in our 
analyses, have also been implicated in previous studies on radiation, it 
renders reliability to our study (Turtoi and Schneeweiss, 2009, Li et al., 2014). 
Hence, even those putative genes that we determined to be deregulated, 
from our analyses, is worth further investigation by other techniques as 
Reverse-transcriptase PCR and/or in more extensive studies following 





5.1 Understanding the effects of radiation 
Since the discovery of X-rays by the German physicist Wilhelm Rӧntgen more 
than a century ago in 1895, many different sources of radiation have been 
discovered and their applicability in different fields is still expanding. Humans 
are exposed to ionising radiation not only through background radiation, but 
also through the ubiquitous presence of devices and sources that generate 
ionising radiation, thanks to advances in technology, diagnostics, and air and 
space travel etc. With the expanded use of radiation in day to day life, the 
chances of accidents or misuse only increase. A thorough understanding of 
the effects of radiation exposure on biological entities is sine qua non in the 
present world (Barnard et al., 2013). 
Damage to the DNA is the origin of the mutagenic and carcinogenic effects of 
radiation. Therefore, it is the quality and structure of the DNA which were the 
first properties to be checked for the effect of radiation. The effects depend on 
much variability such as the levels, the type of radiation, the time frame of 
exposure and the levels of shielding (Barnard et al., 2013, Kabacik et al., 
2011). Among various types of damages produced by radiation, DSBs are 
believed to be responsible for most of the severe biological consequences 
(Obe et al., 2010). Although a cell has many ways to deal with DNA damage, 
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a small subset of DSBs are either not repaired or misrepaired. This kind of 
aberrations can result in different kinds of structural abnormalities. This can 
influence the cells to respond in many different ways. The effects depend on 
the capacity of the cells to recognise and repair the damage which has 
profound long-term effects such as the initiation of tumourigenesis (Fokas et 
al., 2009). 
5.2 Revisiting the various techniques used in 
biomarker studies of gamma radiation exposure 
The used cytogenetic techniques allowed the observation of the effects of 
radiation exposure. The discovery of the chromosome number and structure 
have been important breakthroughs to analyse changes which even now, 
decades after the discovery, provide us with useful information about the 
severity of the induced effects. With the use FISH assays, we can get detailed 
information of induced effects (Tucker et al., 1995, Obe et al., 2010). Recent 
developments made possible to probe for specific loci or structure in the 
chromosome. During this study, we observed that the cytogenetic techniques 
are giving most information about the initial effects induced by radiation 
exposure; this is the case for heavy ion as well as for gamma radiation. These 
techniques have been shown valuable in assessing dose estimation and 
however, each of these techniques has its limitations. Depending on the 
situation and logistics, these techniques will provide valuable information 
(Grace et al., 2010). In mass triage scenario, when a big population is 
exposed to unknown doses, the first decisions will be made upon physical 
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symptoms. Nausea, vomiting and anorexia are all signs of acute radiation 
syndrome which show up within 24 hours of exposure when exposed to high 
doses of radiation. When patients display these kinds of symptoms, they 
might be in life threatening danger and need medical attention immediately. 
Biomarkers at higher doses can be helpful in attributing the observed physical 
symptoms to radiation exposure. The focus of this study was on the 
exposures to the doses between 0.1 and 1 Gy, a dose range where no 
physical symptoms will be manifested within 24 hours. Thus, especially in the 
case of mass radiation casualties, it is important to be able to give rapid dose 
estimation. This will help in medical logistics as well as alleviate the panic 
which goes around during such an event. In case of mass casualty, more 
hospitals or clinics will be involved which should give similar information. 
Therefore, it is important to have biodosimeters in place which can be used at 
different places and give similar clarity. In the first part of this study, we have 
shown that different available techniques can be used to make reliable dose 
estimation as they all show dose-dependent results even after low dose of 
exposure (0.1-1.0 Gy) to gamma radiation. Dicentric assay is currently the 
method of choice and is very sensitive to radiation exposure as the formation 
of dicentric is a unique feature observed after radiation exposure (Prasanna 
et al., 2010). The drawback is the time taken to process the samples, as it 
takes 48 hours before the results can be analysed.  In addition, analysis is 
time consuming and requires experienced personnel. Therefore, dicentric 
analysis can be used if available personnel can handle the number of people 
involved in the event to be tested.  
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Detection of H2AX using immunofluorescence, an indication of prevalence of 
DSBs in a cell, can be deployed as a high-speed method and gives almost 
immediate results, although this is not specific to radiation. Nonetheless, an 
overall dose-dependent increase was observed in our study, corroborating 
with earlier studies and hence, can be used as initial indicator of the need for 
any medical attention. However, as observed in our study, since H2AX foci 
follow a rapid kinetics of occurrence and decay, the time of exposure needs to 
be known and facilities need to be available to be able to analyse reliably and 
in a high-throughput manner. In case of a immediate response after radiation 
exposure, H2AX foci estimation emerges as a viable option (Wang et al., 
2014). 
CBMN is a technique that can be used in an automated system, so if skilled 
personnel is lacking, this is a suitable option although results can be analysed 
only after 72 hours. Analysis is fairly straight-forward and can give results 
within minutes. So the choice of technique to be used really depends on the 
logistics and the urgency of the situation (Vral et al., 2011).  
Gene expression analysis can be a robust method to detect radiation 
biomarkers as this can be automated, personnel limited experience the field 
will be able to analyse the data and results will be out within a few hours. We 
see that the many variables such as type of radiation, time after exposure, 
dose and inter-individual variation have sizeable influence on the gene 
expression (Dressman et al., 2007, Paul and Amundson, 2011). Extensive 
efforts are currently made to increase the pool of data available about gene 
expression response to radiation exposure so that this can be used as 
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biodosimeter. While more information is currently available for exposure to 
gamma radiation, and while therefore, gene expression analysis after 
exposure to gamma radiation seems more reliable and applicable, the 
potential biomarkers found after heavy ion radiation might prove to be 
valuable in the future when more extensive studies confirm these results. 
5.3 Assessment of the immediate effects of 
radiation with direct applicability to real-time 
scenarios 
Radiation exposure results in a dynamic cellular response within the cells. In 
this study, we have chosen to analyse effects at 2 and 24 hour after 
irradiation. This is done as 2 hours is assumed to be the earliest time point 
people could be sent to hospitals in case of accidental exposure (Turtoi et al., 
2008). For triage management, the medical logistics should be in place so 
that patients can be screened as soon as possible following the radiation 
exposure; therefore a two hours post irradiation will be a reasonably 
achievable time point which is relevant for screening methods. While in some 
cases, it might take longer duration to reach the accident site for emergency 
personnel and 24 hours post radiation time point is relevant for space 
exploration or to analyse the effects after a medical treatment with 
radiotherapy (Delaney et al., 2005). It will be informative to determine the 
biomarkers which persist for 24 hours in the body, this can be used as 
screening methods to analyse effects of certain treatment, or space mission 
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(Hellweg and Baumstark-Khan, 2007). Analysing expression of genes at 
these time points might therefore facilitate to identify valuable details about 
gene response after radiation exposure. This can help to gain a better 
understanding about the response activated after radiation exposure. And 
besides being suitable biomarkers, this will assist in elucidating the 
mechanism behind the effects of radiotherapy. 
In this study, we have seen that gene response at 2 hours is very different 
from that at 24 hours after radiation exposure, this highlights once again that  
gene expression regulation is a dynamic event within a cell and that, the time 
after exposure is an important factor for any kind of dose estimation. It is 
suggested that gene expression profiling could be added to the list of 
biodosimeters such as dicentric and MN analysis, which are currently in use 
and such gene profiling can be concurrently used along with the existing 
biodosimetry modalities. 
5.4 Effects of heavy ions radiation on human 
lymphocytes 
The application and relevance of heavy ions stem from two disparate aspects: 
one from the ability of heavy ions like carbon ions to supplant conventional 
gamma radiation for use in radiotherapy, owing to its higher penetrance and 
greater localising power, especially in inaccessible solid tumours. Secondly, 
from the realisation that heavy ions from iron ions contributes to maximal 
energy of such radiation and is particularly pertinent in case of exposure 
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issues as in manned interplanetary space missions. Thus, it is of high 
importance that the effects of heavy ion radiation be analysed and thoroughly 
understood. In our study, we see a clear difference in the way heavy ions 
damage the DNA, therefore it is not surprising that the observed gene 
expression profiles are very distinct from those of gamma radiation exposure. 
The way a cell responds to DNA damage and the signalling circuitry which 
determines cell fate might be the understood by such analyses. To 
supplement our use of cells from three healthy donors, more extensive 
studies and further validation of the identified genes could enhance the 
applicability of such findings in real life scenarios of radiation exposure. 
5.5 Final remarks 
To recapitulate, our results of the cytogenetic experiments corroborate in 
terms of the dose dependency of occurrence of various aberrations, and the 
prevalence of aberrant cells with previously reported ones. In addition, we 
delineated the different sources of radiation by analysing different patterns of 
MN and chromosomal aberrations in the human lymphocytes. Our study also 
unravelled both – previously documented genes to be implicated upon 
irradiation, and also putative ones, thus establishing a reliability of our results, 
while adding onto the available knowledge in literature.  
The search for the ultimate biomarker(s) (analogous to the search of the 
ultimate oncogene/ tumour-suppressor gene in cancer biology) is still on, 
when it comes to radiation exposures. While some of the techniques 
deployed in the study are standard methods of choice in radiation 
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biodosimetry and risk estimation, clearly each one of them have their own 
limitations – either in terms of persistence of their end point parameters, or in 
their labour intensive and time consuming methodology or in the ambiguity of 
their generation in cells, to name a few. From our analyses of multiple 
parameters of both – cell-by-cell data (using the cytogenetic and 
immunofluorescence techniques) and high-throughput data (using genome-
wide gene expression microarray) – on the same samples, and by doing so in 
three different sources of radiation, we realise that and would like to 
propagate an integrated approach – one that involves combining parts of 
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